Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Bruker Corporation (BRKR)
USD59.31
+0.34 (+0.58%)
US NASDAQ Healthcare Medical - Devices
Address
40 Manning Road 1821
Billerica, MA, US
Billerica, MA, US
CEO
Frank H. Laukien
Website
bruker.com
IPO
2000-08-04
CIK 1109354 ISIN US1167941087
Also trades on
NASDAQ Global Select · BRKR (USD)
NASDAQ Global Select · BRKRP (USD)
Description
Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| Article IX | BDAL | 2003-05-01 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD59.31
+0.34 (+0.58%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
1.30
Float Shares
103.57M
Free Float %
68.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.02% | +1.19% | +15.11% | +15.36% | +1.84% | -8.15% | +7.48% | -41.33% | -34.88% | +60.50% | +87.64% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (32 ratings, all time)
Buy
Price Targets & DCF
Current price
59.31
Low
35.00
-41.0%
Consensus
51.22
-13.6%
Median
53.00
-10.6%
High
60.00
+1.2%
DCF (Unlevered)
56.32
-5.1%
DCF (Levered)
20.26
-65.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
64% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 7 | 0 |
| Hold | 4 | -1 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 4 |
46.00
-22.4%
|
| Last Year | 17 |
49.18
-17.1%
|
| All Time | 22 |
54.68
-7.8%
|
Quality scores
Altman Z-Score
2.39
Grey zone
Piotroski F-Score
3 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+2.1% Q1'26: +2.7% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-119.7% Q1'26: -79.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-0.7% Q1'26: +5.7% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%+2.4% Q1'26: +5.5% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%+1.2% Q1'26: +3.8% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+1.5% Q1'26: +0.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×6.75× Q1'26: 4.04× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 9 Rev. Ana. 6 EPS Ana. |
Dec 2027 9 Rev. Ana. 6 EPS Ana. |
Dec 2028 7 Rev. Ana. 1 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 6 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.65B
est: 1.75B (-5.8%)
|
1.79B
est: 1.68B (+6.3%)
|
1.84B
est: 2.02B (-9.1%)
|
1.81B
est: 1.70B (+6.3%)
|
1.62B
est: 1.62B (+0.5%)
|
1.61B
est: 1.61B (+0.2%)
|
1.77B
est: 1.74B (+1.3%)
|
1.90B
est: 1.89B (+0.4%)
|
2.07B
est: 2.05B (+1.3%)
|
1.99B
est: 1.96B (+1.3%)
|
2.42B
est: 2.40B (+0.8%)
|
2.53B
est: 2.50B (+1.2%)
|
2.96B
est: 3.12B (-5.0%)
|
3.37B
est: 3.36B (+0.1%)
|
3.44B
est: 3.42B (+0.4%)
|
3.59B
3.58B – 3.62B
+4.9% YoY
|
3.74B
3.70B – 3.77B
+4.3% YoY
|
3.95B
3.94B – 3.95B
+5.4% YoY
|
4.20B
4.17B – 4.23B
+6.5% YoY
|
4.28B
4.25B – 4.31B
+1.9% YoY
|
| EBITDA |
205.70M
est: 157.23M (+30.8%)
|
211.70M
est: 125.14M (+69.2%)
|
239.10M
est: 186.12M (+28.5%)
|
215.60M
est: 158.72M (+35.8%)
|
235.90M
est: 131.76M (+79.0%)
|
262.10M
est: 167.16M (+56.8%)
|
299.50M
est: 255.79M (+17.1%)
|
340.10M
est: 296.62M (+14.7%)
|
372.00M
est: 353.66M (+5.2%)
|
320.60M
est: 309.21M (+3.7%)
|
497.10M
est: 383.11M (+29.8%)
|
518.70M
est: 437.93M (+18.4%)
|
675.50M
est: 534.57M (+26.4%)
|
438.60M
est: 576.08M (-23.9%)
|
302.60M
est: 586.38M (-48.4%)
|
614.96M
613.25M – 619.68M
+4.9% YoY
|
641.58M
634.72M – 646.73M
+4.3% YoY
|
676.09M
675.70M – 676.48M
+5.4% YoY
|
719.97M
714.23M – 725.49M
+6.5% YoY
|
733.29M
727.44M – 738.92M
+1.9% YoY
|
| EBIT |
152.80M
est: 162.57M (-6.0%)
|
152.60M
est: 128.35M (+18.9%)
|
177.80M
est: 135.59M (+31.1%)
|
114.60M
est: 95.89M (+19.5%)
|
182.60M
est: 100.70M (+81.3%)
|
207.80M
est: 119.19M (+74.3%)
|
235.60M
est: 200.09M (+17.7%)
|
275.20M
est: 242.81M (+13.3%)
|
296.40M
est: 288.98M (+2.6%)
|
240.20M
est: 235.14M (+2.2%)
|
407.90M
est: 326.05M (+25.1%)
|
430.00M
est: 366.97M (+17.2%)
|
560.60M
est: 391.43M (+43.2%)
|
254.80M
est: 421.83M (-39.6%)
|
82.30M
est: 429.37M (-80.8%)
|
450.30M
449.05M – 453.75M
+4.9% YoY
|
469.79M
464.77M – 473.56M
+4.3% YoY
|
495.06M
494.78M – 495.35M
+5.4% YoY
|
527.19M
522.99M – 531.24M
+6.5% YoY
|
536.95M
532.67M – 541.07M
+1.9% YoY
|
| Net Income |
92.30M
est: 95.46M (-3.3%)
|
77.50M
est: 61.56M (+25.9%)
|
80.10M
est: 72.84M (+10.0%)
|
56.70M
est: 52.51M (+8.0%)
|
101.60M
est: 70.63M (+43.9%)
|
153.60M
est: 101.34M (+51.6%)
|
78.60M
est: 70.96M (+10.8%)
|
179.70M
est: 167.12M (+7.5%)
|
197.20M
est: 187.33M (+5.3%)
|
157.80M
est: 148.62M (+6.2%)
|
277.10M
est: 215.24M (+28.7%)
|
296.60M
est: 241.59M (+22.8%)
|
427.20M
est: 365.64M (+16.8%)
|
113.10M
est: 362.36M (-68.8%)
|
-8.60M
est: 286.04M (-103.0%)
|
320.87M
318.59M – 323.14M
+12.2% YoY
|
364.66M
350.01M – 379.31M
+13.6% YoY
|
421.47M
417.18M – 425.75M
+15.6% YoY
|
476.49M
471.55M – 481.25M
+13.1% YoY
|
520.67M
515.28M – 525.87M
+9.3% YoY
|
| SGA |
403.60M
est: 428.09M (-5.7%)
|
442.40M
est: 403.68M (+9.6%)
|
437.90M
est: 440.77M (-0.7%)
|
451.00M
est: 437.67M (+3.0%)
|
392.20M
est: 286.48M (+36.9%)
|
390.50M
est: 279.12M (+39.9%)
|
415.90M
est: 388.14M (+7.2%)
|
444.70M
est: 422.42M (+5.3%)
|
504.80M
est: 472.07M (+6.9%)
|
477.80M
est: 520.63M (-8.2%)
|
562.30M
est: 441.81M (+27.3%)
|
607.40M
est: 535.90M (+13.3%)
|
729.40M
est: 785.88M (-7.2%)
|
893.80M
est: 846.91M (+5.5%)
|
946.50M
est: 862.05M (+9.8%)
|
904.07M
901.55M – 911.01M
+4.9% YoY
|
943.21M
933.12M – 950.77M
+4.3% YoY
|
993.94M
993.37M – 994.52M
+5.4% YoY
|
1.06B
1.05B – 1.07B
+6.5% YoY
|
1.08B
1.07B – 1.09B
+1.9% YoY
|
| EPS |
0.56
est: 0.91 (-38.5%)
|
0.47
est: 0.60 (-21.7%)
|
0.48
est: 0.77 (-37.7%)
|
0.34
est: 0.68 (-50.0%)
|
0.60
est: 0.78 (-23.4%)
|
0.95
est: 1.12 (-15.2%)
|
0.50
est: 1.19 (-58.0%)
|
1.15
est: 1.40 (-17.8%)
|
1.27
est: 1.63 (-22.1%)
|
1.03
est: 1.33 (-22.6%)
|
1.83
est: 2.09 (-12.6%)
|
2.00
est: 2.32 (-13.8%)
|
2.92
est: 2.41 (+21.2%)
|
0.76
est: 2.39 (-68.2%)
|
-0.15
est: 1.88 (-108.0%)
|
2.12
2.10 – 2.13
+12.4% YoY
|
2.42
2.31 – 2.50
+14.1% YoY
|
2.78
2.75 – 2.80
+14.9% YoY
|
3.14
3.11 – 3.17
+13.0% YoY
|
3.43
3.39 – 3.46
+9.3% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-15 | Barclays | Overweight | Overweight | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-05 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-04 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-01 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-15 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
54.11M
OE per share TTM
0.35
Owner's Yield
0.84%
Maintenance CapEx ratio
133.43%
Maint CapEx / Avg PPE
22.7%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
90
Total invested
482.75M
Insider transactions (90d)
0
Beneficial owners (>5%)
11
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Abigail P. Johnson | 22.97M | 15.00% | — | — | 22.97M | — | IN | Delaware | 2021-02-08 | ↗ |
| 2 | FMR LLC | 22.97M | 15.00% | 2.32M | — | 22.97M | — | HC | Delaware | 2021-02-08 | ↗ |
| 3 | 13G | 18.20M | 11.00% | 18.20M | — | 18.20M | — | IN | Germany | 2015-02-11 | ↗ |
| 4 | 85-4328500 | 16.57M | 11.00% | 6.34M | — | 16.57M | — | IA | Maryland | 2022-08-10 | ↗ |
| 5 | Edward C. Johnson 3d | 13.06M | 7.75% | — | — | 13.06M | — | IN | United States of America | 2015-02-13 | ↗ |
| 6 | Dirk D. Laukien | 12.32M | 7.40% | 12.32M | — | 12.32M | — | IN | United States | 2013-01-30 | ↗ |
| 7 | (1) BlackRock, Inc. | 10.84M | 7.20% | 10.42M | — | 10.84M | — | HC | Delaware | 2022-02-04 | ↗ |
| 8 | The Vanguard Group - 23-1945930 | 10.77M | 7.10% | — | 64.6K | 10.61M | 158.0K | IA | Pennsylvania | 2022-02-09 | ↗ |
| 9 | Joerg C. Laukien | 7.52M | 5.10% | 7.52M | — | 7.52M | — | IN | Germany | 2023-01-23 | ↗ |
| 10 | 04-2747644 | 7.51M | 5.10% | 7.16M | — | 7.51M | — | IA | Delaware | 2023-02-08 | ↗ |
| 11 | 52-0556948 | 2.96M | 1.90% | 627.0K | — | 2.96M | — | IA | Maryland | 2022-08-10 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
90
-280 vs prev Q
New positions
13
Closed positions
279
Increased
41
Reduced
28
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | MACQUARIE MANAGEMENT HOLDINGS, INC. | 419.6K +419.6K (+100.0%) | 19.77B +19.8B (+100.0%) | 0.28% +0.276 pp | 0.03% +0.030 pp | USD47.11 +0.0% | 1 qtrs NEW |
| 2 | FMR LLC | 15.23M +1.5M (+10.9%) | 717.47M +271.3M (+60.8%) | 10.02% +0.961 pp | 0.04% +0.013 pp | USD42.56 +10.7% | 70 qtrs — |
| 3 | ORBIS ALLAN GRAY LTD | 14.91M +761.3K (+5.4%) | 702.26M +242.7M (+52.8%) | 9.81% +0.476 pp | 2.94% +0.970 pp | USD35.97 +31.0% | 3 qtrs — |
| 4 | BLACKROCK, INC. | 10.97M +14.8K (+0.1%) | 516.89M +160.9M (+45.2%) | 7.22% -0.009 pp | 0.01% +0.003 pp | USD67.58 -30.3% | 6 qtrs — |
| 5 | VANGUARD GROUP INC | 10.26M -144.4K (-1.4%) | 483.34M +145.3M (+43.0%) | 6.75% -0.113 pp | 0.01% +0.002 pp | USD68.17 -30.9% | 84 qtrs — |
| 6 | PALLAS CAPITAL ADVISORS LLC | 9.48M +114.0 (+0.0%) | 446.63M +138.6M (+45.0%) | 6.25% -0.008 pp | 14.75% +3.415 pp | USD75.03 -37.2% | 20 qtrs — |
| 7 | STATE STREET CORP | 3.83M +91.7K (+2.5%) | 180.70M +59.0M (+48.5%) | 2.52% +0.054 pp | 0.01% +0.002 pp | USD56.08 -16.0% | 51 qtrs — |
| 8 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 3.19M -3.2M (-50.0%) | 150.23M -57.0M (-27.5%) | 2.10% -2.108 pp | 0.09% -0.032 pp | USD53.53 -12.0% | 14 qtrs — |
| 9 | SCULPTOR CAPITAL LP | 3.00M -74.8K (-2.4%) | 141.33M +41.4M (+41.5%) | 1.97% -0.055 pp | 1.46% +0.276 pp | USD52.06 -9.5% | 6 qtrs — |
| 10 | EDMOND DE ROTHSCHILD HOLDING S.A. | 2.86M -310.7K (-9.8%) | 134.55M +31.7M (+30.8%) | 1.88% -0.210 pp | 1.91% +0.321 pp | USD36.63 +28.6% | 3 qtrs — |
| 11 | LONDON CO OF VIRGINIA | 2.78M -225.4K (-7.5%) | 131.11M +33.4M (+34.1%) | 1.83% -0.154 pp | 0.76% +0.217 pp | USD74.10 -36.4% | 35 qtrs — |
| 12 | BROWN ADVISORY INC | 2.41M -437.2K (-15.4%) | 113.44M +21.0M (+22.7%) | 1.58% -0.293 pp | 0.16% +0.038 pp | USD48.48 -2.8% | 25 qtrs — |
| 13 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.37M +2.3M (+2,963.4%) | 111.49M +109.0M (+4,341.8%) | 1.56% +1.506 pp | 0.01% +0.012 pp | USD46.27 +1.8% | 75 qtrs — |
| 14 | FRANKLIN RESOURCES INC | 2.31M +1.8M (+317.7%) | 108.80M +90.8M (+505.6%) | 1.52% +1.157 pp | 0.03% +0.022 pp | USD43.72 +7.8% | 21 qtrs — |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 2.07M -12.2K (-0.6%) | 97.67M +29.9M (+44.2%) | 1.36% -0.012 pp | 0.01% +0.002 pp | USD41.56 +13.4% | 78 qtrs — |
| 16 | DIMENSIONAL FUND ADVISORS LP | 1.89M -100.1K (-5.0%) | 89.19M +24.4M (+37.7%) | 1.25% -0.068 pp | 0.02% +0.005 pp | USD39.69 +18.7% | 51 qtrs — |
| 17 | MILLENNIUM MANAGEMENT LLC | 1.84M +1.3M (+222.6%) | 86.66M +68.1M (+367.7%) | 1.21% +0.834 pp | 0.04% +0.029 pp | USD43.08 +9.4% | 58 qtrs — |
| 18 | MORGAN STANLEY | 1.68M -508.9K (-23.3%) | 79.00M +8.0M (+11.2%) | 1.10% -0.339 pp | 0.00% +0.000 pp | USD51.75 -9.0% | 51 qtrs — |
| 19 | VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | 1.64M -449.4K (-21.5%) | 77.29M +9.4M (+13.8%) | 1.08% -0.298 pp | 0.76% +0.138 pp | USD45.22 +4.2% | 10 qtrs — |
| 20 | FIL LTD | 1.61M +426.2K (+36.0%) | 75.86M +37.4M (+97.2%) | 1.06% +0.278 pp | 0.06% +0.027 pp | USD56.26 -16.3% | 6 qtrs — |
| 21 | POINT72 ASSET MANAGEMENT, L.P. | 1.55M +491.4K (+46.3%) | 73.16M +38.7M (+112.1%) | 1.02% +0.322 pp | 0.08% +0.024 pp | USD37.12 +26.9% | 2 qtrs — |
| 22 | CITADEL ADVISORS LLC | 1.42M +103.8K (+7.9%) | 66.87M +24.1M (+56.4%) | 0.93% +0.066 pp | 0.01% +0.004 pp | USD45.46 +3.6% | 52 qtrs — |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.35M +24.8K (+1.9%) | 63.58M +20.5M (+47.7%) | 0.89% +0.014 pp | 0.01% +0.003 pp | USD38.81 +21.4% | 90 qtrs — |
| 24 | SAMLYN CAPITAL, LLC | 1.32M +601.9K (+84.2%) | 62.05M +38.8M (+167.0%) | 0.87% +0.395 pp | 0.99% +0.669 pp | USD39.17 +20.3% | 2 qtrs — |
| 25 | ARTISAN PARTNERS LIMITED PARTNERSHIP | 1.19M +771.5K (+183.2%) | 56.19M +42.5M (+310.6%) | 0.78% +0.507 pp | 0.08% +0.065 pp | USD41.95 +12.3% | 2 qtrs — |
| 26 | M&G PLC | 1.14M +44.8K (+4.1%) | 53.63M +18.6M (+52.9%) | 0.75% +0.029 pp | 0.28% +0.089 pp | USD35.68 +32.0% | 4 qtrs — |
| 27 | FIRST TRUST ADVISORS LP | 1.13M +338.2K (+42.9%) | 53.09M +27.5M (+107.2%) | 0.74% +0.221 pp | 0.04% +0.020 pp | USD67.75 -30.5% | 35 qtrs — |
| 28 | MARSHALL WACE, LLP | 1.09M +1.1M (+100.0%) | 51.53M +51.5M (+100.0%) | 0.72% +0.720 pp | 0.05% +0.047 pp | USD47.11 +0.0% | 8 qtrs — |
| 29 | UBS GROUP AG | 1.00M -413.5K (-29.2%) | 47.13M +1.2M (+2.6%) | 0.66% -0.275 pp | 0.01% +0.000 pp | USD39.96 +17.9% | 45 qtrs — |
| 30 | BANK OF AMERICA CORP /DE/ | 964.0K -113.8K (-10.6%) | 45.41M +10.4M (+29.7%) | 0.63% -0.077 pp | 0.00% +0.001 pp | USD47.71 -1.3% | 52 qtrs — |
| 31 | NORTHERN TRUST CORP | 933.2K -15.4K (-1.6%) | 43.96M +13.1M (+42.7%) | 0.61% -0.012 pp | 0.01% +0.002 pp | USD51.42 -8.4% | 51 qtrs — |
| 32 | NUVEEN, LLC | 916.4K +150.1K (+19.6%) | 43.17M +18.3M (+73.4%) | 0.60% +0.097 pp | 0.01% +0.005 pp | USD36.93 +27.6% | 4 qtrs — |
| 33 | BNP PARIBAS ARBITRAGE, SNC | 842.1K +319.7K (+61.2%) | 39.67M +22.7M (+133.8%) | 0.55% +0.209 pp | 0.02% +0.009 pp | USD42.84 +10.0% | 38 qtrs — |
| 34 | BANK OF NEW YORK MELLON CORP | 836.3K -21.6K (-2.5%) | 39.40M +11.5M (+41.3%) | 0.55% -0.015 pp | 0.01% +0.002 pp | USD58.73 -19.8% | 66 qtrs — |
| 35 | IRON TRIANGLE PARTNERS LP | 794.4K +794.4K (+100.0%) | 37.42M +37.4M (+100.0%) | 0.52% +0.523 pp | 4.28% +4.279 pp | USD47.11 +0.0% | 1 qtrs NEW |
| 36 | ROYAL LONDON ASSET MANAGEMENT LTD | 788.3K +11.5K (+1.5%) | 37.14M +11.9M (+47.2%) | 0.52% +0.006 pp | 0.08% +0.024 pp | USD41.29 +14.1% | 3 qtrs — |
| 37 | EVERSEPT PARTNERS, LP | 783.8K +96.7K (+14.1%) | 36.92M +14.6M (+65.4%) | 0.52% +0.062 pp | 1.86% +0.322 pp | USD46.35 +1.6% | 5 qtrs — |
| 38 | CHAMPLAIN INVESTMENT PARTNERS, LLC | 752.0K +417.9K (+125.1%) | 35.43M +24.6M (+226.3%) | 0.49% +0.274 pp | 0.36% +0.277 pp | USD44.46 +6.0% | 3 qtrs — |
| 39 | FREESTONE GROVE PARTNERS LP | 685.9K +204.0K (+42.3%) | 32.31M +16.7M (+106.4%) | 0.45% +0.133 pp | 0.23% +0.117 pp | USD36.84 +27.9% | 2 qtrs — |
| 40 | OLD WEST INVESTMENT MANAGEMENT, LLC | 684.8K +111.3K (+19.4%) | 32.26M +13.6M (+73.1%) | 0.45% +0.072 pp | 5.76% +1.486 pp | USD37.88 +24.4% | 4 qtrs — |
| 41 | PRIMECAP MANAGEMENT CO/CA/ | 655.1K +655.1K (+100.0%) | 30.86M +30.9M (+100.0%) | 0.43% +0.432 pp | 0.02% +0.023 pp | USD47.11 +0.0% | 1 qtrs NEW |
| 42 | NATIXIS ADVISORS, L.P. | 635.9K +8.3K (+1.3%) | 29.96M +9.6M (+46.9%) | 0.42% +0.005 pp | 0.04% +0.013 pp | USD51.86 -9.2% | 11 qtrs — |
| 43 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 609.0K -222.8K (-26.8%) | 28.69M +1.7M (+6.2%) | 0.40% -0.148 pp | 0.10% +0.010 pp | USD34.70 +35.8% | 25 qtrs — |
| 44 | DEKABANK DEUTSCHE GIROZENTRALE | 307.0K +— (+0.0%) | 27.33M +17.8M (+186.0%) | 0.20% -0.001 pp | 0.05% +0.031 pp | USD76.30 -38.3% | 12 qtrs — |
| 45 | ORBIMED ADVISORS LLC | 555.8K +555.8K (+100.0%) | 26.18M +26.2M (+100.0%) | 0.37% +0.366 pp | 0.54% +0.537 pp | USD47.11 +0.0% | 1 qtrs NEW |
| 46 | CANDRIAM S.C.A. | 547.6K +45.9K (+9.2%) | 25.80M +9.5M (+58.3%) | 0.36% +0.029 pp | 0.13% +0.043 pp | USD47.89 -1.6% | 21 qtrs — |
| 47 | GOLDMAN SACHS GROUP INC | 522.4K -102.6K (-16.4%) | 24.61M +4.3M (+21.2%) | 0.34% -0.069 pp | 0.00% +0.001 pp | USD51.40 -8.3% | 73 qtrs — |
| 48 | METLIFE INVESTMENT MANAGEMENT, LLC | 503.1K -2.7K (-0.5%) | 23.70M +7.3M (+44.2%) | 0.33% -0.002 pp | 0.11% +0.036 pp | USD44.93 +4.9% | 17 qtrs — |
| 49 | PALISADE CAPITAL MANAGEMENT, LP | 490.0K -256.1K (-34.3%) | 23.08M -1.2M (-4.8%) | 0.32% -0.170 pp | 0.68% +0.026 pp | USD38.26 +23.1% | 55 qtrs — |
| 50 | NEW YORK STATE COMMON RETIREMENT FUND | 486.1K +115.3K (+31.1%) | 22.90M +10.9M (+90.1%) | 0.32% +0.076 pp | 0.03% +0.015 pp | USD38.99 +20.8% | 90 qtrs — |
| 51 | AMERIPRISE FINANCIAL INC | 481.6K -53.4K (-10.0%) | 22.69M +5.3M (+30.5%) | 0.32% -0.036 pp | 0.01% +0.001 pp | USD66.00 -28.6% | 55 qtrs — |
| 52 | LOOMIS SAYLES & CO L P | 448.2K +84.0K (+23.1%) | 21.11M +9.3M (+78.4%) | 0.30% +0.055 pp | 0.03% +0.011 pp | USD41.98 +12.2% | 4 qtrs — |
| 53 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 437.7K -135.5K (-23.6%) | 20.79M +2.2M (+11.6%) | 0.29% -0.090 pp | 0.03% +0.003 pp | USD41.32 +14.0% | 4 qtrs — |
| 54 | TWO SIGMA INVESTMENTS, LP | 421.6K -425.7K (-50.2%) | 19.86M -7.7M (-27.9%) | 0.28% -0.282 pp | 0.03% -0.013 pp | USD45.37 +3.8% | 19 qtrs — |
| 55 | BECKER CAPITAL MANAGEMENT INC | 404.0K +102.8K (+34.1%) | 19.05M +9.3M (+94.4%) | 0.27% +0.067 pp | 0.55% +0.259 pp | USD37.13 +26.9% | 3 qtrs — |
| 56 | NEEDHAM INVESTMENT MANAGEMENT LLC | 364.7K -35.4K (-8.8%) | 17.18M +4.2M (+32.2%) | 0.24% -0.024 pp | 1.09% +0.179 pp | USD51.36 -8.3% | 26 qtrs — |
| 57 | CEREDEX VALUE ADVISORS LLC | 362.9K -133.1K (-26.8%) | 17.10M +981.2K (+6.1%) | 0.24% -0.088 pp | 0.51% +0.140 pp | USD42.87 +9.9% | 5 qtrs — |
| 58 | NAN FUNG TRINITY (HK) LTD | 355.3K +355.3K (+100.0%) | 16.74M +16.7M (+100.0%) | 0.23% +0.234 pp | 1.33% +1.326 pp | USD47.11 +0.0% | 1 qtrs NEW |
| 59 | D. E. SHAW & CO., INC. | 317.5K +111.6K (+54.2%) | 14.96M +8.3M (+123.6%) | 0.21% +0.073 pp | 0.01% +0.004 pp | USD37.63 +25.2% | 4 qtrs — |
| 60 | GOTHAM ASSET MANAGEMENT, LLC | 308.1K +49.3K (+19.1%) | 14.52M +6.1M (+72.6%) | 0.20% +0.032 pp | 0.05% +0.016 pp | USD45.40 +3.8% | 19 qtrs — |
| 61 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 301.7K +301.7K (+100.0%) | 14.21M +14.2M (+100.0%) | 0.20% +0.199 pp | 0.22% +0.219 pp | USD47.11 +0.0% | 3 qtrs — |
| 62 | ALLIANCEBERNSTEIN L.P. | 298.1K -83.3K (-21.8%) | 14.04M +1.7M (+13.3%) | 0.20% -0.056 pp | 0.00% +0.001 pp | USD40.90 +15.2% | 61 qtrs — |
| 63 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 294.1K +108.3K (+58.3%) | 13.86M +7.8M (+129.5%) | 0.19% +0.071 pp | 0.00% +0.001 pp | USD38.93 +21.0% | 19 qtrs — |
| 64 | BARCLAYS PLC | 289.4K +233.7K (+419.8%) | 13.64M +9.8M (+254.6%) | 0.19% +0.154 pp | 0.00% +0.002 pp | USD50.32 -6.4% | 51 qtrs — |
| 65 | WESLEYAN ASSURANCE SOCIETY | 285.0K +— (+0.0%) | 13.43M +4.2M (+45.0%) | 0.19% 0.000 pp | 0.77% +0.221 pp | USD41.53 +13.4% | 4 qtrs — |
| 66 | RHUMBLINE ADVISERS | 283.5K -11.6K (-3.9%) | 13.35M +3.8M (+39.3%) | 0.19% -0.008 pp | 0.01% +0.003 pp | USD62.38 -24.5% | 55 qtrs — |
| 67 | GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC | 277.8K -192.9K (-41.0%) | 13.09M -2.2M (-14.4%) | 0.18% -0.128 pp | 0.03% -0.010 pp | USD41.56 +13.4% | 4 qtrs — |
| 68 | ENVESTNET ASSET MANAGEMENT INC | 273.7K +3.8K (+1.4%) | 12.90M +4.1M (+47.0%) | 0.18% +0.002 pp | 0.00% +0.001 pp | USD63.09 -25.3% | 42 qtrs — |
| 69 | JPMORGAN CHASE & CO | 273.6K -33.0K (-10.8%) | 12.89M +2.9M (+29.4%) | 0.18% -0.022 pp | 0.00% +0.000 pp | USD46.44 +1.4% | 41 qtrs — |
| 70 | UBS ASSET MANAGEMENT AMERICAS INC | 272.7K +4.8K (+1.8%) | 12.85M +4.1M (+47.6%) | 0.18% +0.003 pp | 0.00% +0.001 pp | USD50.38 -6.5% | 66 qtrs — |
| 71 | CITIGROUP INC | 263.0K +201.1K (+325.3%) | 12.39M +10.4M (+516.6%) | 0.17% +0.132 pp | 0.01% +0.005 pp | USD49.40 -4.6% | 65 qtrs — |
| 72 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 255.4K +70.5K (+38.2%) | 12.29M +5.9M (+91.4%) | 0.17% +0.046 pp | 0.02% +0.010 pp | USD61.21 -23.0% | 17 qtrs — |
| 73 | CI INVESTMENTS INC. | 254.8K +124.5K (+95.6%) | 12.00M +7.8M (+183.7%) | 0.17% +0.082 pp | 0.05% +0.037 pp | USD40.35 +16.8% | 22 qtrs — |
| 74 | SECTOR GAMMA AS | 254.7K +3.8K (+1.5%) | 12.00M +3.8M (+47.2%) | 0.17% +0.002 pp | 2.74% +0.714 pp | USD51.15 -7.9% | 27 qtrs — |
| 75 | RAYMOND JAMES FINANCIAL INC | 245.2K +127.4K (+108.1%) | 11.55M +7.7M (+201.7%) | 0.16% +0.084 pp | 0.00% +0.002 pp | USD41.78 +12.8% | 5 qtrs — |
| 76 | PRINCIPAL FINANCIAL GROUP INC | 238.4K -7.5K (-3.0%) | 11.23M +3.2M (+40.6%) | 0.16% -0.005 pp | 0.01% +0.002 pp | USD78.57 -40.0% | 65 qtrs — |
| 77 | INVESCO LTD. | 231.2K -14.3K (-5.8%) | 10.89M +2.9M (+36.6%) | 0.15% -0.010 pp | 0.00% +0.000 pp | USD53.65 -12.2% | 57 qtrs — |
| 78 | SEI INVESTMENTS CO | 216.1K +88.4K (+69.2%) | 10.18M +6.0M (+145.4%) | 0.14% +0.058 pp | 0.01% +0.006 pp | USD50.13 -6.0% | 45 qtrs — |
| 79 | TD ASSET MANAGEMENT INC | 215.4K -211.8K (-49.6%) | 10.15M -3.7M (-26.9%) | 0.14% -0.140 pp | 0.01% -0.003 pp | USD61.00 -22.8% | 51 qtrs — |
| 80 | OMERS ADMINISTRATION CORP | 212.2K +— (+0.0%) | 10.00M +3.1M (+45.0%) | 0.14% 0.000 pp | 0.07% +0.022 pp | USD66.92 -29.6% | 9 qtrs — |
| 81 | SWISS NATIONAL BANK | 209.5K +3.9K (+1.9%) | 9.87M +3.2M (+47.7%) | 0.14% +0.002 pp | 0.01% +0.002 pp | USD36.49 +29.1% | 51 qtrs — |
| 82 | EDENTREE ASSET MANAGEMENT LTD | 198.8K -180.8K (-47.6%) | 9.37M -3.0M (-24.1%) | 0.13% -0.120 pp | 2.87% -0.102 pp | USD50.22 -6.2% | 11 qtrs — |
| 83 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 187.2K +29.4K (+18.6%) | 8.82M +3.7M (+72.0%) | 0.12% +0.019 pp | 0.01% +0.002 pp | USD39.24 +20.1% | 58 qtrs — |
| 84 | THRIVENT FINANCIAL FOR LUTHERANS | 179.8K +152.6K (+561.3%) | 8.47M +7.6M (+859.2%) | 0.12% +0.101 pp | 0.02% +0.013 pp | USD49.30 -4.4% | 30 qtrs — |
| 85 | MONTANARO ASSET MANAGEMENT LTD | 173.5K -47.1K (-21.4%) | 8.17M +1.0M (+14.0%) | 0.11% -0.031 pp | 2.28% +0.488 pp | USD60.35 -21.9% | 21 qtrs — |
| 86 | WELLINGTON MANAGEMENT GROUP LLP | 173.5K +173.5K (+100.0%) | 8.17M +8.2M (+100.0%) | 0.11% +0.114 pp | 0.00% +0.001 pp | USD47.11 +0.0% | 1 qtrs NEW |
| 87 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 164.9K -35.1K (-17.6%) | 7.77M +1.3M (+19.5%) | 0.11% -0.024 pp | 0.01% +0.002 pp | USD41.20 +14.3% | 3 qtrs — |
| 88 | LEGAL & GENERAL GROUP PLC | 162.3K -43.6K (-21.2%) | 7.65M +958.3K (+14.3%) | 0.11% -0.029 pp | 0.00% +0.000 pp | USD62.97 -25.2% | 44 qtrs — |
| 89 | WELLS FARGO & COMPANY/MN | 156.8K -62.7K (-28.6%) | 7.39M +255.4K (+3.6%) | 0.10% -0.042 pp | 0.00% +0.000 pp | USD65.64 -28.2% | 57 qtrs — |
| 90 | RHENMAN & PARTNERS ASSET MANAGEMENT AB | 147.3K -7.0K (-4.5%) | 6.94M +1.9M (+38.4%) | 0.10% -0.005 pp | 0.65% +0.094 pp | USD46.29 +1.8% | 9 qtrs — |
| 91 | PEREGRINE CAPITAL MANAGEMENT LLC | 138.8K +138.3K (+27,660.8%) | 6.54M +6.5M (+40,152.7%) | 0.09% +0.091 pp | 0.20% +0.200 pp | USD47.06 +0.1% | 2 qtrs — |
| 92 | LOMBARD ODIER ASSET MANAGEMENT (EUROPE) LTD | 136.2K +136.2K (+100.0%) | 6.42M +6.4M (+100.0%) | 0.09% +0.090 pp | 0.32% +0.318 pp | USD47.11 +0.0% | 1 qtrs NEW |
| 93 | RETIREMENT SYSTEMS OF ALABAMA | 133.1K -792.0 (-0.6%) | 6.27M +1.9M (+44.1%) | 0.09% -0.001 pp | 0.02% +0.006 pp | USD81.47 -42.2% | 17 qtrs — |
| 94 | LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE | 131.5K -80.6K (-38.0%) | 6.20M -694.0K (-10.1%) | 0.09% -0.053 pp | 1.84% +0.586 pp | USD41.72 +12.9% | 4 qtrs — |
| 95 | INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 125.0K +125.0K (+100.0%) | 5.89M +5.9M (+100.0%) | 0.08% +0.082 pp | 0.29% +0.292 pp | USD47.11 +0.0% | 1 qtrs NEW |
| 96 | DNB ASSET MANAGEMENT AS | 124.1K -19.2K (-13.4%) | 5.85M +1.2M (+25.6%) | 0.08% -0.013 pp | 0.02% +0.003 pp | USD38.69 +21.8% | 3 qtrs — |
| 97 | STATE OF WISCONSIN INVESTMENT BOARD | 117.4K -18.4K (-13.6%) | 5.53M +1.1M (+25.3%) | 0.08% -0.012 pp | 0.01% +0.002 pp | USD55.03 -14.4% | 51 qtrs — |
| 98 | PICTET ASSET MANAGEMENT HOLDING SA | 115.1K -33.1K (-22.3%) | 5.42M +606.9K (+12.6%) | 0.08% -0.022 pp | 0.01% +0.001 pp | USD47.41 -0.6% | 10 qtrs — |
| 99 | TUDOR INVESTMENT CORP ET AL | 106.7K +6.7K (+6.7%) | 5.02M +1.8M (+54.7%) | 0.07% +0.004 pp | 0.01% +0.004 pp | USD33.40 +41.0% | 20 qtrs — |
| 100 | VELA INVESTMENT MANAGEMENT, LLC | 102.7K +34.7K (+51.0%) | 4.84M +2.6M (+119.0%) | 0.07% +0.023 pp | 1.14% +0.599 pp | USD45.23 +4.2% | 5 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 162 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | ProShares - Nanotechnology ETF TINY | 6.51% | 3.08M | 0.58% |
| 2 | First Trust NYSE Arca Biotechnology Index Fund FBT | 4.28% | 120.68M | 0.55% |
| 3 | First Trust NYSE Arca Biotechnology UCITS ETF FBTU.L | 3.74% | 528.1K | 0.60% |
| 4 | Ballast Small/Mid Cap ETF MGMT | 2.03% | 3.05M | 1.10% |
| 5 | State Street SPDR S&P Kensho Future Security ETF FITE | 1.42% | 2.12M | 0.45% |
| 6 | Hedgeye 130/30 Equity ETF HELS | 1.24% | 492.6K | 0.70% |
| 7 | Hedgeye Quality Growth ETF HGRO | 1.07% | 455.6K | 0.70% |
| 8 | State Street SPDR S&P Kensho New Economies Composite ETF KOMP | 1.01% | 27.50M | 0.20% |
| 9 | iShares Health Innovation Active ETF BMED | 1.00% | 110.8K | 0.77% |
| 10 | JPMorgan Active Small Cap Value ETF JPSV | 0.81% | 216.9K | 0.55% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.50
Neutral
Ratio by volume
0.50
Neutral
Buys
1
Sells
2
Shares acquired
2.0K
Shares disposed
4.0K
Cash buys
—
Cash sales
1.00
Net activity
-2,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-15 | Munch Mark | Officer | M-Exempt | A | Common Stock | 2,000 | 22.19 | 44.4K | 130,443 | D | ↗ |
| 2026-04-01 | Bernard Thierry | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-13 | Munch Mark | Officer | M-Exempt | A | Common Stock | 2,000 | 22.19 | 44.4K | 130,443 | D | ↗ |
| 2026-02-15 | Requardt Hermann Fritz | Director | A-Award | A | Common Stock | 4,520 | 0.00 | — | 30,965 | D | ↗ |
| 2026-02-15 | ROSENTHAL BOB | Director | A-Award | A | Common Stock | 4,520 | 0.00 | — | 38,781 | D | ↗ |
| 2026-02-15 | Phillips Jack | Director | A-Award | A | Common Stock | 4,520 | 0.00 | — | 4,520 | D | ↗ |
| 2026-02-15 | Perkins Adelene Q | Director | A-Award | A | Common Stock | 4,520 | 0.00 | — | 29,144 | D | ↗ |
| 2026-02-15 | PACKER RICHARD A | Director | A-Award | A | Common Stock | 4,520 | 0.00 | — | 93,694 | D | ↗ |
| 2026-02-15 | ORNELL JOHN A | Director | A-Award | A | Common Stock | 4,520 | 0.00 | — | 39,732 | D | ↗ |
| 2026-02-15 | LINTON WILLIAM A | Director | A-Award | A | Common Stock | 4,520 | 0.00 | — | 63,243 | D | ↗ |
| 2026-02-15 | Friend Cynthia M | Director | A-Award | A | Common Stock | 4,520 | 0.00 | — | 22,536 | D | ↗ |
| 2026-02-15 | FRANCIS LAURA | Director | A-Award | A | Common Stock | 4,520 | 0.00 | — | 9,018 | D | ↗ |
| 2026-02-15 | Bures Thomas | Officer | F-InKind | D | Common Stock | 274 | 36.51 | 10.0K | 3,198 | D | ↗ |
| 2026-02-15 | Anderson Bonnie H | Director | A-Award | A | Common Stock | 4,520 | 0.00 | — | 17,847 | D | ↗ |
| 2026-02-13 | Munch Mark | Officer | M-Exempt | A | Common Stock | 2,000 | 22.19 | 44.4K | 130,443 | D | ↗ |
| 2026-01-15 | Munch Mark | Officer | S-Sale | D | Common Stock | 2,000 | 49.20 | 98.4K | 128,443 | D | ↗ |
| 2026-01-12 | Munch Mark | Officer | M-Exempt | A | Common Stock | 7,000 | 22.19 | 155.3K | 135,443 | D | ↗ |
| 2026-01-05 | Munch Mark | Officer | M-Exempt | A | Common Stock | 4,506 | 22.19 | 100.0K | 132,949 | D | ↗ |
| 2026-01-01 | Phillips Jack | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-12-01 | PACKER RICHARD A | Director | M-Exempt | A | Common Stock | 10,000 | 24.00 | 240.0K | 94,202 | D | ↗ |
| 2025-11-06 | ORNELL JOHN A | Director | M-Exempt | A | Stock Option (right to buy) | 10,000 | 24.00 | 240.0K | 10,000 | D | ↗ |
| 2025-09-12 | Friend Cynthia M | Director | M-Exempt | A | Common Stock | 4,300 | 26.17 | 112.5K | 21,551 | D | ↗ |
| 2025-08-15 | Prause Burkhard | Officer | A-Award | A | Stock Option (Right to Purchase) | 5,008 | 33.52 | 167.9K | 5,008 | D | ↗ |
| 2025-08-15 | Munch Mark | Officer | A-Award | A | Stock Option (Right to Purchase) | 22,337 | 33.52 | 748.7K | 22,337 | D | ↗ |
| 2025-08-15 | LAUKIEN FRANK H | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Purchase) | 137,339 | 36.87 | 5.06M | 137,339 | D | ↗ |
| 2025-08-15 | Herman Gerald N | Officer | A-Award | A | Stock Option (Right to Purchase) | 24,430 | 36.87 | 900.8K | 24,430 | D | ↗ |
| 2025-08-15 | Busse Falko | Officer | A-Award | A | Stock Option (Right to Purchase) | 8,774 | 33.52 | 294.1K | 8,774 | D | ↗ |
| 2025-08-11 | Munch Mark | Officer | F-InKind | D | Common Stock | 1,279 | 30.78 | 39.4K | 104,812 | D | ↗ |
| 2025-08-11 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 4,838 | 30.78 | 148.9K | 38,445,672 | D | ↗ |
| 2025-08-11 | Herman Gerald N | Officer | F-InKind | D | Common Stock | 1,420 | 30.78 | 43.7K | 76,739 | D | ↗ |
| 2025-08-10 | Munch Mark | Officer | F-InKind | D | Common Stock | 1,107 | 30.43 | 33.7K | 106,091 | D | ↗ |
| 2025-08-10 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 4,657 | 30.43 | 141.7K | 38,450,510 | D | ↗ |
| 2025-08-10 | Herman Gerald N | Officer | F-InKind | D | Common Stock | 1,380 | 30.43 | 42.0K | 78,159 | D | ↗ |
| 2025-08-09 | Munch Mark | Officer | F-InKind | D | Common Stock | 1,340 | 30.43 | 40.8K | 107,198 | D | ↗ |
| 2025-08-09 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 3,422 | 30.43 | 104.1K | 38,455,167 | D | ↗ |
| 2025-08-09 | Herman Gerald N | Officer | F-InKind | D | Common Stock | 1,846 | 30.43 | 56.2K | 79,539 | D | ↗ |
| 2025-08-05 | Munch Mark | Officer | F-InKind | D | Common Stock | 844 | 32.07 | 27.1K | 108,538 | D | ↗ |
| 2025-08-05 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 3,582 | 32.07 | 114.9K | 38,458,589 | D | ↗ |
| 2025-08-05 | Herman Gerald N | Officer | F-InKind | D | Common Stock | 577 | 32.07 | 18.5K | 81,385 | D | ↗ |
| 2025-06-06 | LAUKIEN FRANK H | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,608 | 38.36 | 100.0K | 38,462,171 | D | ↗ |
| 2025-05-15 | FRANCIS LAURA | Director | A-Award | A | Common Stock | 4,498 | 0.00 | — | 4,498 | D | ↗ |
| 2025-05-13 | ORNELL JOHN A | Director | M-Exempt | A | Common Stock | 5,000 | 18.15 | 90.8K | 31,445 | D | ↗ |
| 2025-04-22 | LINTON WILLIAM A | Director | M-Exempt | A | Common Stock | 10,000 | 24.00 | 240.0K | 58,723 | D | ↗ |
| 2025-03-10 | Bures Thomas | Officer | P-Purchase | A | Common Stock | 500 | 47.40 | 23.7K | 3,472 | D | ↗ |
| 2025-02-18 | LAUKIEN FRANK H | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 6,937 | 51.23 | 355.4K | 38,459,563 | D | ↗ |
| 2025-02-18 | FRANCIS LAURA | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-02-15 | Requardt Hermann Fritz | Director | A-Award | A | Common Stock | 3,298 | 0.00 | — | 26,445 | D | ↗ |
| 2025-02-15 | ROSENTHAL BOB | Director | A-Award | A | Common Stock | 3,298 | 0.00 | — | 34,261 | D | ↗ |
| 2025-02-15 | Perkins Adelene Q | Director | A-Award | A | Common Stock | 3,298 | 0.00 | — | 24,624 | D | ↗ |
| 2025-02-15 | PACKER RICHARD A | Director | A-Award | A | Common Stock | 3,298 | 0.00 | — | 84,202 | D | ↗ |
| 2025-02-15 | ORNELL JOHN A | Director | A-Award | A | Common Stock | 3,298 | 0.00 | — | 26,445 | D | ↗ |
| 2025-02-15 | LINTON WILLIAM A | Director | A-Award | A | Common Stock | 3,298 | 0.00 | — | 48,723 | D | ↗ |
| 2025-02-15 | Friend Cynthia M | Director | A-Award | A | Common Stock | 3,298 | 0.00 | — | 17,251 | D | ↗ |
| 2025-02-15 | Bures Thomas | Officer | A-Award | A | Common Stock | 2,972 | 0.00 | — | 2,972 | D | ↗ |
| 2025-02-15 | Anderson Bonnie H | Director | A-Award | A | Common Stock | 3,298 | 0.00 | — | 13,327 | D | ↗ |
| 2025-01-13 | Bures Thomas | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-12-02 | PACKER RICHARD A | Director | S-Sale | D | Common Stock | 3,350 | 57.82 | 193.7K | 80,904 | D | ↗ |
| 2024-11-22 | LINTON WILLIAM A | Director | M-Exempt | D | Stock Option (Right to Buy) | 10,000 | 19.12 | 191.2K | 0 | D | ↗ |
| 2024-11-18 | LAUKIEN FRANK H | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 26,551 | 50.82 | 1.35M | 38,435,980 | D | ↗ |
| 2024-08-15 | ROSENTHAL BOB | Director | M-Exempt | A | Common Stock | 10,000 | 24.00 | 240.0K | 35,647 | — | ↗ |
| 2024-08-11 | Munch Mark | Officer | F-InKind | D | Common Stock | 1,618 | 60.42 | 97.8K | 109,382 | — | ↗ |
| 2024-08-11 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 4,838 | 60.42 | 292.3K | 38,339,563 | — | ↗ |
| 2024-08-11 | Herman Gerald N | Officer | F-InKind | D | Common Stock | 1,067 | 60.42 | 64.5K | 81,962 | — | ↗ |
| 2024-08-10 | Munch Mark | Officer | F-InKind | D | Common Stock | 1,573 | 60.42 | 95.0K | 111,000 | — | ↗ |
| 2024-08-10 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 4,657 | 60.42 | 281.4K | 38,344,401 | — | ↗ |
| 2024-08-10 | Herman Gerald N | Officer | F-InKind | D | Common Stock | 1,471 | 60.42 | 88.9K | 83,029 | — | ↗ |
| 2024-08-09 | Srega Juergen | Officer | A-Award | A | Stock Option (Right to Purchase) | 15,407 | 62.00 | 955.2K | 28,892 | — | ↗ |
| 2024-08-09 | Prause Burkhard | Officer | A-Award | A | Stock Option (Right to Purchase) | 2,543 | 62.00 | 157.7K | 2,543 | — | ↗ |
| 2024-08-09 | Munch Mark | Officer | A-Award | A | Common Stock | 15,022 | 0.00 | — | 112,573 | — | ↗ |
| 2024-08-09 | LAUKIEN FRANK H | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Purchase) | 77,255 | 68.20 | 5.27M | 2,543 | — | ↗ |
| 2024-08-09 | Herman Gerald N | Officer | A-Award | A | Common Stock | 15,106 | 0.00 | — | 84,500 | — | ↗ |
| 2024-08-09 | Busse Falko | Officer | A-Award | A | Stock Option (Right to Purchase) | 5,486 | 62.00 | 340.1K | 5,486 | — | ↗ |
| 2024-08-06 | Munch Mark | Officer | F-InKind | D | Common Stock | 2,174 | 62.16 | 135.1K | 97,551 | — | ↗ |
| 2024-08-06 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,174 | 62.16 | 135.1K | 38,320,751 | — | ↗ |
| 2024-08-06 | Herman Gerald N | Officer | F-InKind | D | Common Stock | 988 | 62.16 | 61.4K | 69,394 | — | ↗ |
| 2024-08-05 | Munch Mark | Officer | F-InKind | D | Common Stock | 986 | 63.54 | 62.7K | 99,725 | — | ↗ |
| 2024-08-05 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 3,582 | 63.54 | 227.6K | 38,322,925 | — | ↗ |
| 2024-08-05 | Herman Gerald N | Officer | F-InKind | D | Common Stock | 577 | 63.54 | 36.7K | 70,382 | — | ↗ |
| 2024-03-04 | Requardt Hermann Fritz | Director | M-Exempt | A | Common Stock | 10,000 | 24.00 | 240.0K | 38,147 | — | ↗ |
| 2024-02-28 | Busse Falko | Officer | S-Sale | D | Common Stock | 12,770 | 84.97 | 1.09M | 34,359 | — | ↗ |
| 2024-02-22 | Prause Burkhard | Officer | M-Exempt | A | Common Stock | 1,846 | 43.50 | 80.3K | 28,780 | — | ↗ |
| 2024-01-05 | Requardt Hermann Fritz | Director | A-Award | A | Common Stock | 2,377 | 0.00 | — | 23,147 | — | ↗ |
| 2024-01-05 | ROSENTHAL BOB | Director | A-Award | A | Common Stock | 2,377 | 0.00 | — | 23,147 | — | ↗ |
| 2024-01-05 | Perkins Adelene Q | Director | A-Award | A | Common Stock | 2,377 | 0.00 | — | 21,326 | — | ↗ |
| 2024-01-05 | PACKER RICHARD A | Director | A-Award | A | Common Stock | 2,377 | 0.00 | — | 74,254 | — | ↗ |
| 2024-01-05 | ORNELL JOHN A | Director | A-Award | A | Common Stock | 2,377 | 0.00 | — | 23,147 | — | ↗ |
| 2024-01-05 | Ma Philip | Director | A-Award | A | Common Stock | 2,377 | 0.00 | — | 5,963 | — | ↗ |
| 2024-01-05 | LINTON WILLIAM A | Director | A-Award | A | Common Stock | 2,377 | 0.00 | — | 35,425 | — | ↗ |
| 2024-01-05 | Friend Cynthia M | Director | A-Award | A | Common Stock | 2,377 | 0.00 | — | 13,953 | — | ↗ |
| 2024-01-05 | Anderson Bonnie H | Director | A-Award | A | Common Stock | 2,377 | 0.00 | — | 10,029 | — | ↗ |
| 2023-12-27 | Srega Juergen | Officer | F-InKind | D | Common Stock | 4,840 | 73.63 | 356.4K | 140,791 | — | ↗ |
| 2023-12-16 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 1,404 | 73.36 | 103.0K | 38,326,507 | — | ↗ |
| 2023-12-05 | LINTON WILLIAM A | Director | M-Exempt | A | Common Stock | 10,000 | 19.07 | 190.7K | 33,048 | — | ↗ |
| 2023-10-26 | LAUKIEN FRANK H | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 57,356 | 46.15 | 2.65M | 38,327,911 | — | ↗ |
| 2023-08-11 | Munch Mark | Officer | F-InKind | D | Common Stock | 1,578 | 66.96 | 105.7K | 100,711 | — | ↗ |
| 2023-08-11 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 4,421 | 66.96 | 296.0K | 38,268,388 | — | ↗ |
| 2023-08-11 | Herman Gerald N | Officer | F-InKind | D | Common Stock | 913 | 66.96 | 61.1K | 70,959 | — | ↗ |
| 2023-08-10 | Srega Juergen | Officer | A-Award | A | Stock Option (Right to Purchase) | 13,485 | 66.35 | 894.7K | 13,485 | — | ↗ |
| 2023-08-10 | Prause Burkhard | Officer | A-Award | A | Stock Option (Right to Purchase) | 2,176 | 66.35 | 144.4K | 2,176 | — | ↗ |
| 2023-08-10 | Munch Mark | Officer | A-Award | A | Stock Option (Right to Purchase) | 11,388 | 66.35 | 755.6K | 11,388 | — | ↗ |
| 2023-08-10 | LAUKIEN FRANK H | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Purchase) | 35,349 | 72.99 | 2.58M | 35,349 | — | ↗ |
| 2023-08-10 | Herman Gerald N | Officer | A-Award | A | Common Stock | 12,168 | 0.00 | — | 71,872 | — | ↗ |
| 2023-08-10 | Busse Falko | Officer | A-Award | A | Common Stock | 4,526 | 0.00 | — | 32,859 | — | ↗ |
| 2023-08-09 | Munch Mark | Officer | F-InKind | D | Common Stock | 2,141 | 65.68 | 140.6K | 80,179 | — | ↗ |
| 2023-08-09 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 5,722 | 65.68 | 375.8K | 38,234,288 | — | ↗ |
| 2023-08-09 | Herman Gerald N | Officer | F-InKind | D | Common Stock | 722 | 65.68 | 47.4K | 34,304 | — | ↗ |
| 2023-08-08 | LAUKIEN FRANK H | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 44,150 | 47.85 | 2.11M | 38,255,291 | — | ↗ |
| 2023-08-07 | Munch Mark | Officer | F-InKind | D | Common Stock | 2,744 | 66.75 | 183.2K | 84,268 | — | ↗ |
| 2023-08-07 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 9,078 | 66.75 | 606.0K | 38,245,803 | — | ↗ |
| 2023-08-07 | Herman Gerald N | Officer | F-InKind | D | Common Stock | 1,436 | 66.75 | 95.9K | 35,903 | — | ↗ |
| 2023-07-27 | LAUKIEN FRANK H | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 2,672 | 37.42 | 100.0K | 38,183,306 | — | ↗ |
| 2023-06-16 | Herman Gerald N | Officer | S-Sale | D | Common Stock | 14,242 | 75.42 | 1.07M | 36,462 | — | ↗ |
| 2023-05-19 | Kastner Marc A | Director | S-Sale | D | Common Stock | 11,146 | 75.22 | 838.4K | 8,051 | — | ↗ |
| 2023-05-16 | LAUKIEN FRANK H | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 12,917 | 73.03 | 943.3K | 38,210,993 | — | ↗ |
| 2023-05-15 | LAUKIEN FRANK H | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 137,718 | 72.60 | 10.00M | 38,352,034 | — | ↗ |
| 2023-05-09 | LAUKIEN FRANK H | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 30,359 | 74.44 | 2.26M | 38,180,634 | — | ↗ |
| 2023-05-08 | LAUKIEN FRANK H | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 81,745 | 76.99 | 6.29M | 38,352,034 | — | ↗ |
| 2023-05-03 | LAUKIEN FRANK H | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 16,435 | 79.21 | 1.30M | 38,352,034 | — | ↗ |
| 2023-05-02 | LAUKIEN FRANK H | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 49,476 | 78.27 | 3.87M | 38,161,517 | — | ↗ |
| 2023-05-01 | LAUKIEN FRANK H | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,901 | 79.38 | 627.2K | 38,262,287 | — | ↗ |
| 2023-04-25 | LAUKIEN FRANK H | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 13,793 | 77.87 | 1.07M | 38,298,156 | — | ↗ |
| 2023-04-24 | LAUKIEN FRANK H | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 146,122 | 81.01 | 11.84M | 38,352,034 | — | ↗ |
| 2023-01-17 | Friend Cynthia M | Director | S-Sale | D | Common Stock | 921 | 68.26 | 62.9K | 11,576 | — | ↗ |
| 2023-01-05 | Requardt Hermann Fritz | Director | A-Award | A | Common Stock | 1,970 | 0.00 | — | 20,770 | — | ↗ |
| 2023-01-05 | ROSENTHAL BOB | Director | A-Award | A | Common Stock | 1,970 | 0.00 | — | 20,770 | — | ↗ |
| 2023-01-05 | Perkins Adelene Q | Director | A-Award | A | Common Stock | 1,970 | 0.00 | — | 18,949 | — | ↗ |
| 2023-01-05 | PACKER RICHARD A | Director | A-Award | A | Common Stock | 1,970 | 0.00 | — | 71,877 | — | ↗ |
| 2023-01-05 | ORNELL JOHN A | Director | A-Award | A | Common Stock | 1,970 | 0.00 | — | 20,770 | — | ↗ |
| 2023-01-05 | Ma Philip | Director | A-Award | A | Common Stock | 1,970 | 0.00 | — | 3,586 | — | ↗ |
| 2023-01-05 | LINTON WILLIAM A | Director | A-Award | A | Common Stock | 1,970 | 0.00 | — | 23,048 | — | ↗ |
| 2023-01-05 | Kastner Marc A | Director | A-Award | A | Common Stock | 1,970 | 0.00 | — | 20,021 | — | ↗ |
| 2023-01-05 | Friend Cynthia M | Director | A-Award | A | Common Stock | 1,970 | 0.00 | — | 12,497 | — | ↗ |
| 2023-01-05 | Anderson Bonnie H | Director | A-Award | A | Common Stock | 1,970 | 0.00 | — | 7,652 | — | ↗ |
| 2022-12-16 | LAUKIEN FRANK H | Director | F-InKind | D | Common Stock | 1,243 | 64.41 | 80.1K | 38,500,264 | — | ↗ |
| 2022-12-06 | PACKER RICHARD A | Director | M-Exempt | D | Stock Option (Right to Buy) | 10,000 | 0.00 | — | 0 | — | ↗ |
| 2022-12-06 | LINTON WILLIAM A | Director | M-Exempt | D | Stock Option (Right to Buy) | 10,000 | 0.00 | — | 0 | — | ↗ |
| 2022-11-15 | Kastner Marc A | Director | M-Exempt | A | Common Stock | 10,000 | 24.00 | 240.0K | 18,051 | — | ↗ |
| 2022-08-11 | Prause Burkhard | Officer | A-Award | A | Stock Option (Right to Buy) | 2,472 | 62.00 | 153.3K | 2,472 | — | ↗ |
| 2022-08-11 | Munch Mark | Director | A-Award | A | Common Stock | 12,770 | 0.00 | — | 89,879 | — | ↗ |
| 2022-08-11 | LAUKIEN FRANK H | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 40,550 | 68.20 | 2.77M | 40,550 | — | ↗ |
| 2022-08-11 | Herman Gerald N | Director | A-Award | A | Common Stock | 12,521 | 0.00 | — | 59,704 | — | ↗ |
| 2022-08-11 | Busse Falko | Officer | A-Award | A | Common Stock | 4,658 | 0.00 | — | 28,333 | — | ↗ |
| 2022-08-08 | Munch Mark | Director | F-InKind | D | Common Stock | 2,515 | 60.34 | 151.8K | 77,109 | — | ↗ |
| 2022-08-08 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 5,076 | 62.16 | 315.5K | 38,463,102 | — | ↗ |
| 2022-08-06 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 5,140 | 62.48 | 321.1K | 38,468,178 | — | ↗ |
| 2022-08-05 | Munch Mark | Director | F-InKind | D | Common Stock | 2,127 | 62.48 | 132.9K | 81,765 | — | ↗ |
| 2022-08-05 | LAUKIEN FRANK H | Director | F-InKind | D | Common Stock | 2,915 | 62.48 | 182.1K | 38,473,318 | — | ↗ |
| 2022-05-11 | LAUKIEN FRANK H | Director | P-Purchase | A | Common Stock | 1,710 | 57.64 | 98.6K | 38,476,233 | — | ↗ |
| 2022-04-01 | Ma Philip | Director | A-Award | A | Common Stock | 1,616 | 0.00 | — | 1,616 | — | ↗ |
| 2022-02-18 | LAUKIEN FRANK H | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 40,490 | 29.78 | 1.21M | 38,501,313 | — | ↗ |
| 2022-02-17 | LAUKIEN FRANK H | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 26,200 | 68.12 | 1.78M | 38,460,823 | — | ↗ |
| 2022-01-05 | Requardt Hermann Fritz | Director | A-Award | A | Common Stock | 1,841 | 0.00 | — | 18,800 | — | ↗ |
| 2022-01-05 | ROSENTHAL BOB | Director | A-Award | A | Common Stock | 1,841 | 0.00 | — | 18,800 | — | ↗ |
| 2022-01-05 | Perkins Adelene Q | Director | A-Award | A | Common Stock | 1,841 | 0.00 | — | 16,979 | — | ↗ |
| 2022-01-05 | PACKER RICHARD A | Director | A-Award | A | Common Stock | 1,841 | 0.00 | — | 59,907 | — | ↗ |
| 2022-01-05 | ORNELL JOHN A | Director | A-Award | A | Common Stock | 1,841 | 0.00 | — | 18,800 | — | ↗ |
| 2022-01-05 | LINTON WILLIAM A | Director | A-Award | A | Common Stock | 1,841 | 0.00 | — | 11,078 | — | ↗ |
| 2022-01-05 | Kastner Marc A | Director | A-Award | A | Common Stock | 1,841 | 0.00 | — | 12,987 | — | ↗ |
| 2022-01-05 | Friend Cynthia M | Director | A-Award | A | Common Stock | 1,841 | 0.00 | — | 10,527 | — | ↗ |
| 2022-01-05 | Anderson Bonnie H | Director | A-Award | A | Common Stock | 1,841 | 0.00 | — | 5,682 | — | ↗ |
| 2021-12-16 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 1,243 | 78.78 | 97.9K | 38,443,176 | — | ↗ |
| 2021-12-15 | Munch Mark | Officer | S-Sale | D | Common Stock | 21,210 | 79.47 | 1.69M | 85,064 | — | ↗ |
| 2021-11-24 | Kastner Marc A | Director | M-Exempt | A | Common Stock | 10,000 | 19.90 | 199.0K | 21,146 | — | ↗ |
| 2021-11-02 | LINTON WILLIAM A | Director | M-Exempt | A | Common Stock | 6,000 | 12.77 | 76.6K | 9,237 | — | ↗ |
| 2021-09-02 | Srega Juergen | Officer | M-Exempt | D | Stock Option (Right to Purchase) | 35,438 | 19.82 | 702.4K | 0 | — | ↗ |
| 2021-09-01 | LINTON WILLIAM A | Director | G-Gift | D | Common Stock | 84,472 | 0.00 | — | 3,237 | — | ↗ |
| 2021-08-16 | Prause Burkhard | Officer | M-Exempt | A | Common Stock | 1,903 | 41.95 | 79.8K | 31,646 | — | ↗ |
| 2021-08-16 | LAUKIEN FRANK H | Director / Officer / 10% Owner | M-Exempt | D | Stock Option (Right to Buy) | 129,284 | 24.41 | 3.16M | 0 | — | ↗ |
| 2021-08-10 | Munch Mark | Officer | F-InKind | D | Common Stock | 2,989 | 82.61 | 246.9K | 85,064 | — | ↗ |
| 2021-08-10 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 7,496 | 82.61 | 619.2K | 38,386,729 | — | ↗ |
| 2021-08-09 | Munch Mark | Officer | F-InKind | D | Common Stock | 2,354 | 82.85 | 195.0K | 88,053 | — | ↗ |
| 2021-08-09 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 6,019 | 82.85 | 498.7K | 38,394,225 | — | ↗ |
| 2021-08-06 | Munch Mark | Officer | F-InKind | D | Common Stock | 2,978 | 82.61 | 246.0K | 90,407 | — | ↗ |
| 2021-08-06 | LAUKIEN FRANK H | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 9,225 | 82.61 | 762.1K | 38,400,244 | — | ↗ |
| 2021-08-05 | Srega Juergen | Officer | A-Award | A | Stock Option (Right to Buy) | 14,534 | 81.32 | 1.18M | 14,534 | — | ↗ |
| 2021-08-05 | Prause Burkhard | Officer | A-Award | A | Stock Option (Right to Buy) | 2,258 | 81.32 | 183.6K | 2,258 | — | ↗ |
| 2021-08-05 | Munch Mark | Officer | A-Award | A | Stock Option (Right to Buy) | 11,821 | 81.32 | 961.3K | 11,821 | — | ↗ |
| 2021-08-05 | LAUKIEN FRANK H | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 37,048 | 89.45 | 3.31M | 37,048 | — | ↗ |
| 2021-08-05 | Herman Gerald N | Officer | A-Award | A | Common Stock | 7,851 | 0.00 | — | 47,183 | — | ↗ |
| 2021-08-05 | Busse Falko | Officer | A-Award | A | Stock Option (Right to Buy) | 4,153 | 81.32 | 337.7K | 4,153 | — | ↗ |
| 2021-03-22 | Friend Cynthia M | Director | S-Sale | D | Common Stock | 1,800 | 60.43 | 108.8K | 8,686 | — | ↗ |
| 2021-01-07 | Kastner Marc A | Director | S-Sale | D | Common Stock | 1,236 | 56.56 | 69.9K | 11,146 | — | ↗ |
| 2021-01-05 | Requardt Hermann Fritz | Director | A-Award | A | Common Stock | 2,302 | 0.00 | — | 16,959 | — | ↗ |
| 2021-01-05 | ROSENTHAL BOB | Director | A-Award | A | Common Stock | 2,302 | 0.00 | — | 16,959 | — | ↗ |
| 2021-01-05 | Perkins Adelene Q | Director | A-Award | A | Common Stock | 2,302 | 0.00 | — | 15,138 | — | ↗ |
| 2021-01-05 | PACKER RICHARD A | Director | A-Award | A | Common Stock | 2,302 | 0.00 | — | 58,066 | — | ↗ |
| 2021-01-05 | ORNELL JOHN A | Director | A-Award | A | Common Stock | 2,302 | 0.00 | — | 16,959 | — | ↗ |
| 2021-01-05 | LINTON WILLIAM A | Director | A-Award | A | Common Stock | 2,302 | 0.00 | — | 87,709 | — | ↗ |
| 2021-01-05 | Kastner Marc A | Director | A-Award | A | Common Stock | 2,302 | 0.00 | — | 12,382 | — | ↗ |
| 2021-01-05 | Friend Cynthia M | Director | A-Award | A | Common Stock | 2,302 | 0.00 | — | 9,686 | — | ↗ |
| 2021-01-05 | Anderson Bonnie H | Director | A-Award | A | Common Stock | 2,302 | 0.00 | — | 3,841 | — | ↗ |
| 2020-12-21 | Friend Cynthia M | Director | M-Exempt | D | Stock Option (Right to Buy) | 800 | 26.17 | 20.9K | 0 | — | ↗ |
| 2020-12-15 | Friend Cynthia M | Director | S-Sale | D | Common Stock | 3,473 | 54.95 | 190.8K | 8,384 | — | ↗ |
| 2020-11-10 | Prause Burkhard | Officer | M-Exempt | A | Common Stock | 5,000 | 22.19 | 111.0K | 25,317 | — | ↗ |
| 2020-11-09 | LINTON WILLIAM A | Director | M-Exempt | A | Common Stock | 6,000 | 16.09 | 96.5K | 85,407 | — | ↗ |
| 2020-10-04 | Munch Mark | Officer | F-InKind | D | Common Stock | 1,649 | 38.78 | 63.9K | 86,304 | — | ↗ |
| 2020-09-21 | Friend Cynthia M | Director | S-Sale | D | Common Stock | 800 | 37.58 | 30.1K | 11,857 | — | ↗ |
| 2020-09-03 | Anderson Bonnie H | Director | — | D | No securities are beneficially owned. | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-08-10 | Munch Mark | Officer | F-InKind | D | Common Stock | 7,916 | 44.33 | 350.9K | 87,953 | — | ↗ |
| 2020-08-06 | Srega Juergen | Officer | A-Award | A | Common Stock | 21,726 | 0.00 | — | 131,255 | — | ↗ |
Executive team
Top executives
EBIT / Employee
7.2K
Shares Outstanding
152.22M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Frank H. Laukien, Ph.D. Chairman, President and Chief Executive Officer | 976.6K | — | 1.62M | 1.49M | 587.3K | 31.0K | 4.71M | 66.11% | ↗ |
| 2 | 2025 | Mark R. Munch, Ph.D. Executive Vice President & President, Bruker NANO Group | 738.4K | 200.0K | 792.1K | 266.4K | 153.0K | 28.2K | 2.18M | 48.60% | ↗ |
| 3 | 2025 | Gerald N. Herman Executive Vice President and Chief Financial Officer | 644.2K | — | 866.3K | 264.7K | 215.7K | 19.4K | 2.01M | 56.26% | ↗ |
| 4 | 2025 | Juergen W. Srega President, Bruker CALID Group | 503.8K | — | 487.5K | 162.5K | 174.8K | 94.0K | 1.42M | 45.69% | ↗ |
| 5 | 2025 | Falko Busse, Ph.D. President, Bruker BioSpin Group | 544.6K | 3.6K | 311.1K | 104.7K | 136.5K | 320.3K | 1.42M | 29.26% | ↗ |
| 6 | 2024 | Frank H. Laukien, Ph.D. Chairman, President and Chief Executive Officer | 965.7K | — | 1.76M | 1.58M | 1.19M | 36.0K | 5.53M | 60.39% | ↗ |
| 7 | 2024 | Mark R. Munch, Ph.D. Executive Vice President & President, Bruker NANO Group | 728.2K | 300.0K | 931.4K | 308.1K | 345.8K | 28.6K | 2.64M | 46.91% | ↗ |
| 8 | 2024 | Gerald N. Herman Executive Vice President and Chief Financial Officer | 635.4K | — | 936.6K | 309.8K | 387.5K | 19.0K | 2.29M | 54.47% | ↗ |
| 9 | 2024 | Falko Busse, Ph.D. President, Bruker BioSpin Group | 502.8K | — | 373.9K | 123.7K | 328.5K | 531.0K | 1.86M | 26.75% | ↗ |
| 10 | 2024 | Juergen W. Srega President, Bruker CALID Group | 477.5K | 1.5K | 562.5K | 187.5K | 200.6K | 92.7K | 1.52M | 49.27% | ↗ |
| 11 | 2023 | Frank H. Laukien, Ph.D. Chairman, President and Chief Executive Officer | 926.1K | — | 2.56M | 770.6K | 1.57M | 34.1K | 5.86M | 56.78% | ↗ |
| 12 | 2023 | Mark R. Munch, Ph.D. Executive Vice President & President, Bruker NANO Group | 689.9K | 451.5K | 823.4K | 273.8K | 459.4K | 28.5K | 2.73M | 40.24% | ↗ |
| 13 | 2023 | Gerald N. Herman Executive Vice President and Chief Financial Officer | 603.5K | — | 807.3K | 268.5K | 507.0K | 17.9K | 2.20M | 48.81% | ↗ |
| 14 | 2023 | Falko Busse, Ph.D. President, Bruker BioSpin Group | 468.9K | — | 300.3K | 99.9K | 342.7K | 425.8K | 1.64M | 24.44% | ↗ |
| 15 | 2023 | Juergen W. Srega President, Bruker CALID Group | 452.5K | — | 472.5K | 157.5K | 301.0K | 88.7K | 1.47M | 42.80% | ↗ |
| 16 | 2023 | Juergen Srega President, Bruker CALID Group | 452.5K | — | 472.5K | 157.5K | 301.0K | 88.7K | 1.47M | 42.80% | ↗ |
| 17 | 2022 | Frank H. Laukien, Ph.D. Chairman, President and Chief Executive Officer | 873.3K | — | 2.48M | 760.0K | 906.4K | 36.2K | 5.06M | 64.09% | ↗ |
| 18 | 2022 | Mark R. Munch, Ph.D. Executive Vice President & President Bruker Nano Group | 648.3K | 400.0K | 1.16M | 269.5K | — | 28.0K | 2.50M | 56.97% | ↗ |
| 19 | 2022 | Mark R. Munch, Ph.D. Executive Vice President & President, Bruker NANO Group | 648.3K | 400.0K | 791.7K | 269.5K | 363.7K | 28.0K | 2.50M | 42.43% | ↗ |
| 20 | 2022 | Gerald N. Herman Executive Vice President and Chief Financial Officer | 571.0K | — | 776.3K | 264.3K | 270.6K | 16.5K | 1.90M | 54.81% | ↗ |
| 21 | 2022 | Juergen W. Srega President, Bruker CALID Group | 413.9K | — | 472.6K | 160.9K | 143.2K | 89.9K | 1.28M | 49.47% | ↗ |
| 22 | 2022 | Juergen Srega President, Bruker CALID Group | 413.9K | — | 472.6K | 160.9K | 143.2K | 89.9K | 1.28M | 49.47% | ↗ |
| 23 | 2022 | Falko Busse, Ph.D. President, Bruker BioSpin Group | 425.8K | — | 288.8K | 98.3K | 220.3K | 117.2K | 1.15M | 33.65% | ↗ |
| 24 | 2021 | Frank H. Laukien, Ph.D. Chairman, President and Chief Executive Officer | 811.6K | — | 2.41M | 749.4K | 1.62M | 8.7K | 5.59M | 56.46% | ↗ |
| 25 | 2021 | Mark R. Munch, Ph.D. Executive Vice President & President, Bruker NANO Group | 619.2K | 400.0K | 768.7K | 271.4K | 506.2K | 17.1K | 2.58M | 40.28% | ↗ |
| 26 | 2021 | Mark R. Munch, Ph.D. Executive Vice President & President Bruker Nano Group | 619.2K | 400.0K | 1.27M | 271.4K | — | 17.1K | 2.58M | 59.88% | ↗ |
| 27 | 2021 | Gerald N. Herman Executive Vice President and Chief Financial Officer | 545.3K | — | 638.4K | 225.4K | 522.7K | 8.7K | 1.94M | 44.52% | ↗ |
| 28 | 2021 | Juergen Srega President, Bruker CALID Group | 440.9K | — | 472.6K | 166.9K | 423.7K | 96.2K | 1.60M | 39.96% | ↗ |
| 29 | 2021 | Falko Busse, Ph.D. President, Bruker BioSpin Group | 421.0K | — | 270.1K | 95.4K | 209.0K | 108.6K | 1.10M | 33.10% | ↗ |
| 30 | 2020 | Frank H. Laukien, Ph.D. Chairman, President and Chief Executive Officer | 689.0K | — | 2.73M | 658.4K | — | 8.6K | 4.08M | 82.91% | ↗ |
| 31 | 2020 | Mark R. Munch, Ph.D. Executive Vice President & President Bruker Nano Group | 554.8K | — | 946.8K | 248.9K | — | 17.0K | 1.77M | 67.65% | ↗ |
| 32 | 2020 | Gerald N. Herman Chief Financial Officer | 446.1K | — | 673.3K | 175.1K | — | 8.6K | 1.30M | 65.11% | ↗ |
| 33 | 2020 | Gerald N. Herman Executive Vice President and Chief Financial Officer | 446.1K | — | 673.3K | 175.1K | — | 8.6K | 1.30M | 65.11% | ↗ |
| 34 | 2020 | Juergen Srega President, Bruker CALID Group | 383.7K | — | 632.6K | 157.6K | — | 92.8K | 1.27M | 62.38% | ↗ |
| 35 | 2020 | Falko Busse, Ph.D. President, Bruker BioSpin Group | 373.2K | — | 326.9K | 75.0K | — | 96.7K | 871.8K | 46.10% | ↗ |
| 36 | 2019 | Frank H. Laukien, Ph.D. Chairman, President and Chief Executive Officer | 752.6K | — | 735.3K | 623.8K | — | 8.4K | 4.91M | 27.68% | ↗ |
| 37 | 2019 | Mark R. Munch, Ph.D. Executive Vice President & President Bruker Nano Group | 572.7K | — | 870.1K | 237.7K | — | 16.8K | 1.70M | 65.27% | ↗ |
| 38 | 2019 | Mark R. Munch, Ph.D. Executive Vice President Bruker Nano Group | 572.7K | — | 870.1K | 237.7K | — | 16.8K | 1.70M | 65.27% | ↗ |
| 39 | 2019 | Juergen Srega President, Bruker CALID Group | 374.1K | — | 709.2K | 155.0K | — | 89.6K | 1.33M | 65.08% | ↗ |
| 40 | 2019 | Gerald N. Herman Chief Financial Officer | 443.0K | 100.0K | 561.4K | 135.3K | — | 8.4K | 1.25M | 55.82% | ↗ |
| 41 | 2019 | Gerald N. Herman Executive Vice President and Chief Financial Officer | 443.0K | 100.0K | 561.4K | 135.3K | — | 8.4K | 1.25M | 55.82% | ↗ |
| 42 | 2019 | Falko Busse, Ph.D. President, Bruker BioSpin Group | 355.7K | 45.0K | 283.6K | 55.4K | — | 210.4K | 950.0K | 35.68% | ↗ |
| 43 | 2018 | Frank H. Laukien, Ph.D. Chairman, President and Chief Executive Officer | 730.7K | — | 3.13M | 612.7K | — | 8.3K | 4.48M | 83.51% | ↗ |
| 44 | 2018 | Mark R. Munch, Ph.D. Executive Vice President & President, Bruker Nano Group | 549.3K | — | 1.02M | 230.8K | — | 16.7K | 1.82M | 68.92% | ↗ |
| 45 | 2018 | Mark R. Munch, Ph.D. Executive Vice President & President Bruker Nano Group | 549.3K | — | 1.02M | 230.8K | — | 16.7K | 1.82M | 68.92% | ↗ |
| 46 | 2018 | Mark R. Munch, Ph.D. Executive Vice President Bruker Nano Group | 549.3K | — | 1.02M | 230.8K | — | 16.7K | 1.82M | 68.92% | ↗ |
| 47 | 2018 | Juergen Srega President, Bruker CALID Group | 394.6K | — | 751.2K | 150.5K | — | 94.5K | 1.39M | 64.84% | ↗ |
| 48 | 2018 | Gerald N. Herman Chief Financial Officer | 360.9K | — | 539.4K | 117.9K | — | 8.3K | 1.03M | 64.03% | ↗ |
| 49 | 2018 | Falko Busse, Ph.D. President, Bruker BioSpin Group | 339.5K | — | 236.9K | 44.6K | — | 78.3K | 699.2K | 40.25% | ↗ |
| 50 | 2018 | Anthony L. Mattacchione Former Chief Financial Officer | 114.4K | — | — | — | — | 8.3K | 122.6K | 0.00% | ↗ |
| 51 | 2017 | Frank H. Laukien, Ph.D. Chairman, President and Chief Executive Officer | 704.3K | — | 3.55M | 605.5K | — | 8.1K | 4.87M | 85.38% | ↗ |
| 52 | 2017 | Mark R. Munch, Ph.D. Executive Vice President & President, Bruker Nano Group | 523.1K | — | 1.10M | 215.6K | — | 16.5K | 1.85M | 70.86% | ↗ |
| 53 | 2017 | Mark R. Munch, Ph.D. Executive Vice President Bruker Nano Group | 523.1K | — | 1.10M | 215.6K | — | 16.5K | 1.85M | 70.86% | ↗ |
| 54 | 2017 | Mark R. Munch, Ph.D. Executive Vice President and President, Bruker Nano Group | 523.1K | — | 1.10M | 215.6K | — | 16.5K | 1.85M | 70.86% | ↗ |
| 55 | 2017 | Anthony L. Mattacchione Former Senior Vice President and Chief Financial Officer | 439.4K | — | 1.08M | 204.4K | — | 8.1K | 1.74M | 74.23% | ↗ |
| 56 | 2017 | Anthony L. Mattacchione Former Chief Financial Officer | 439.4K | — | 1.08M | 204.4K | — | 8.1K | 1.74M | 74.23% | ↗ |
| 57 | 2017 | Juergen Srega President, Bruker CALID Group | 369.2K | — | 753.1K | 142.5K | — | 90.4K | 1.36M | 66.08% | ↗ |
| 58 | 2017 | Michael G. Knell Former Vice President and Chief Accounting Officer | 76.2K | — | — | — | — | 121.1K | 197.3K | 0.00% | ↗ |
| 59 | 2016 | Frank H. Laukien, Ph.D. Chairman, President and Chief Executive Officer | 652.5K | — | 1.81M | 968.9K | — | 8.0K | 3.44M | 80.81% | ↗ |
| 60 | 2016 | Mark R. Munch, Ph.D. Executive Vice President & President, Bruker Nano Group | 504.5K | — | 604.7K | 410.1K | — | 15.7K | 1.53M | 66.11% | ↗ |
| 61 | 2016 | Mark R. Munch, Ph.D. Executive Vice President and President, Bruker Nano Group | 504.5K | — | 604.7K | 410.1K | — | 15.7K | 1.53M | 66.11% | ↗ |
| 62 | 2016 | Anthony L. Mattacchione Former Senior Vice President and Chief Financial Officer | 400.7K | 150.0K | 539.5K | 296.6K | — | 8.0K | 1.39M | 59.94% | ↗ |
| 63 | 2016 | Anthony L. Mattacchione Senior Vice President and Chief Financial Officer | 400.7K | 150.0K | 539.5K | 296.6K | — | 8.0K | 1.39M | 59.94% | ↗ |
| 64 | 2016 | Anthony L. Mattacchione Former Chief Financial Officer | 400.7K | 150.0K | 539.5K | 296.6K | — | 8.0K | 1.39M | 59.94% | ↗ |
| 65 | 2016 | René Lenggenhager, Ph.D Former President, Bruker BioSpin Group | 375.7K | — | 267.6K | 125.1K | — | 375.2K | 1.14M | 34.34% | ↗ |
| 66 | 2016 | Juergen Srega President, Bruker CALID Group | 351.1K | — | 359.3K | 275.1K | — | 88.6K | 1.07M | 59.06% | ↗ |
| 67 | 2016 | Michael G. Knell Former Vice President and Chief Accounting Officer | 233.1K | — | 109.6K | 40.8K | — | 8.0K | 391.4K | 38.42% | ↗ |
| 68 | 2015 | Frank H. Laukien, Ph.D. Chairman, President and Chief Executive Officer | 636.3K | — | 3.04M | 248.6K | — | 8.0K | 3.94M | 83.63% | ↗ |
| 69 | 2015 | CALID Mark R. Munch, Ph.D. Executive Vice President and President, Bruker Nano Group | 471.8K | 45.0K | 553.0K | 385.0K | — | 17.1K | 1.47M | 63.73% | ↗ |
| 70 | 2015 | Mark R. Munch, Ph.D. Executive Vice President and President, Bruker Nano Group | 471.8K | 45.0K | 553.0K | 385.0K | — | 17.1K | 1.47M | 63.73% | ↗ |
| 71 | 2015 | Juergen Srega President, Bruker Group | 310.6K | — | 526.4K | 275.0K | — | 87.7K | 1.20M | 66.80% | ↗ |
| 72 | 2015 | Juergen Srega President, Bruker CALID Group | 310.6K | — | 526.4K | 275.0K | — | 87.7K | 1.20M | 66.80% | ↗ |
| 73 | 2015 | Anthony L. Mattacchione Former Senior Vice President and Chief Financial Officer | 322.5K | — | 328.2K | 245.0K | — | 8.0K | 903.7K | 63.43% | ↗ |
| 74 | 2015 | Anthony L. Mattacchione Senior Vice President and Chief Financial Officer | 322.5K | — | 328.2K | 245.0K | — | 5.0K | 900.7K | 63.64% | ↗ |
| 75 | 2015 | Michael G. Knell Vice President and Chief Accounting Officer | 231.7K | — | 172.0K | 72.8K | — | 8.0K | 484.4K | 50.53% | ↗ |
| 76 | 2015 | Michael G. Knell Former Vice President and Chief Accounting Officer | 231.7K | — | 172.0K | 72.8K | — | 8.0K | 484.4K | 50.53% | ↗ |
| 77 | 2015 | Thomas W. Bachmann Former President, Bruker Group | 218.6K | — | — | — | — | 220.8K | 439.5K | 0.00% | ↗ |
| 78 | 2015 | Charles F. Wagner, Jr. Former Executive Vice President and Chief Financial Officer | 261.2K | — | — | — | — | 8.0K | 269.1K | 0.00% | ↗ |
| 79 | 2014 | Frank H. Laukien, Ph.D. Chairman, President | 598.7K | — | 875.0K | 596.8K | 602.3K | 7.8K | 2.68M | 54.91% | ↗ |
| 80 | 2014 | Frank H. Laukien, Ph.D. Chairman, President and Chief Executive Officer | 598.7K | — | 1.48M | 596.8K | — | 7.8K | 2.68M | 77.38% | ↗ |
| 81 | 2014 | Charles F. Wagner, Jr. Executive Vice President and Chief Financial Officer | 509.5K | — | 535.5K | 535.5K | 425.4K | 7.8K | 2.01M | 53.19% | ↗ |
| 82 | 2014 | Charles F. Wagner, Jr. Former Executive Vice President and Chief Financial Officer | 509.5K | — | 960.9K | 535.5K | — | 7.8K | 2.01M | 74.31% | ↗ |
| 83 | 2014 | Juergen Srega President, Bruker CALID Group | 372.3K | 344.9K | 356.7K | 275.0K | — | 105.1K | 1.45M | 43.45% | ↗ |
| 84 | 2014 | Juergen Srega President, Bruker Group | 372.3K | 344.9K | 356.7K | 275.0K | — | 105.1K | 1.45M | 43.45% | ↗ |
| 85 | 2014 | Juergen Srega President, | 372.3K | 344.9K | 275.0K | 275.0K | 81.7K | 105.1K | 1.45M | 37.83% | ↗ |
| 86 | 2014 | CALID Mark R. Munch, Ph.D. Executive Vice President and President, Bruker Nano Group | 399.5K | — | 428.9K | 350.0K | — | 16.2K | 1.19M | 65.20% | ↗ |
| 87 | 2014 | Mark R. Munch, Ph.D. Executive Vice President and President, Bruker Nano Group | 399.5K | — | 428.9K | 350.0K | — | 16.2K | 1.19M | 65.20% | ↗ |
| 88 | 2014 | Mark R. Munch, Ph.D. President, Bruker Nano | 399.5K | — | 350.0K | 350.0K | 78.8K | 16.2K | 1.19M | 58.60% | ↗ |
| 89 | 2014 | Thomas W. Bachmann | 394.0K | — | 283.3K | 121.7K | 90.2K | 13.8K | 945.8K | 42.82% | ↗ |
| 90 | 2014 | Thomas W. Bachmann Former President, Bruker Group | 394.0K | — | 373.5K | 121.7K | — | 56.6K | 945.8K | 52.36% | ↗ |
| 91 | 2014 | Anthony L. Mattacchione Senior Vice President and Chief Financial Officer | 274.0K | — | 122.1K | 187.5K | — | 3.5K | 587.0K | 52.73% | ↗ |
| 92 | 2013 | Frank H. Laukien, Ph.D. Chairman, President | 547.6K | — | 687.5K | 658.9K | 316.8K | 6.1K | 2.22M | 60.73% | ↗ |
| 93 | 2013 | Frank H. Laukien, Ph.D. Chairman, President and Chief Executive Officer | 547.6K | — | 1.00M | 658.9K | — | 6.1K | 2.22M | 75.02% | ↗ |
| 94 | 2013 | Frank H. Laukien Chairman, President and Chief Executive Officer | 547.6K | — | 687.5K | 658.9K | 316.8K | 6.1K | 2.22M | 60.73% | ↗ |
| 95 | 2013 | Juergen Srega President, Bruker | 371.9K | 132.8K | 400.0K | 893.7K | 112.7K | 142.4K | 2.07M | 62.52% | ↗ |
| 96 | 2013 | Juergen Srega President, Bruker | 371.9K | 132.8K | 400.0K | 893.7K | 112.7K | 142.4K | 2.07M | 62.52% | ↗ |
| 97 | 2013 | Juergen Srega President, Bruker Group | 371.9K | 132.8K | 512.7K | 893.7K | — | 142.4K | 2.07M | 67.97% | ↗ |
| 98 | 2013 | Charles F. Wagner, Jr. Former Executive Vice President and Chief Financial Officer | 490.6K | — | 760.5K | 515.5K | — | 7.5K | 1.77M | 71.92% | ↗ |
| 99 | 2013 | Charles F. Wagner, Jr. Executive Vice President and Chief Financial Officer | 490.6K | — | 515.5K | 515.5K | 245.0K | 7.5K | 1.77M | 58.12% | ↗ |
| 100 | 2013 | Mark R. Munch Ph.D. President, Bruker MAT Group and Bruker Nano Surfaces Division | 380.0K | 50.0K | 344.6K | 665.0K | 50.7K | 16.4K | 1.51M | 67.01% | ↗ |
| 101 | 2013 | Mark R. Munch, Ph.D. President, Bruker Nano | 380.0K | 50.0K | 344.6K | 665.0K | 50.7K | 16.4K | 1.51M | 67.01% | ↗ |
| 102 | 2013 | CALID Mark R. Munch, Ph.D. Executive Vice President and President, Bruker Nano Group | 380.0K | 50.0K | 395.3K | 665.0K | — | 16.4K | 1.51M | 70.37% | ↗ |
| 103 | 2013 | Anthony L. Mattacchione Senior Vice President and Chief Financial Officer | 231.5K | 25.0K | 63.1K | 455.3K | — | 2.6K | 777.5K | 66.67% | ↗ |
| 104 | 2013 | Anthony L. Mattacchione Senior Vice President and Chief Financial | 231.5K | 25.0K | — | 455.3K | 63.1K | 2.6K | 777.5K | 58.56% | ↗ |
| 105 | 2012 | Frank H. Laukien Chairman, President and Chief Executive Officer | 444.1K | — | 1.21M | — | 203.0K | 7.5K | 1.86M | 64.82% | ↗ |
| 106 | 2012 | Frank H. Laukien, Ph.D. Chairman, President | 444.1K | — | 1.21M | — | 203.0K | 7.5K | 1.86M | 64.82% | ↗ |
| 107 | 2012 | Charles F. Wagner, Jr. | 275.9K | — | 1,000.0K | 82.7K | 200.0K | 1.0K | 1.56M | 69.22% | ↗ |
| 108 | 2012 | Charles F. Wagner, Jr. Executive Vice President and Chief Financial Officer | 275.9K | — | 1,000.0K | 87.3K | 200.0K | 1.0K | 1.56M | 69.51% | ↗ |
| 109 | 2012 | Burkhard Prause | 236.2K | 104.5K | — | 372.0K | 234.9K | 20.4K | 967.9K | 38.43% | ↗ |
| 110 | 2012 | Mark R. Munch, Ph.D. President, Bruker Nano | 345.4K | — | — | — | 169.1K | 15.9K | 530.3K | 0.00% | ↗ |
| 111 | 2012 | Mark Munch | 345.4K | — | — | — | 169.1K | 15.9K | 530.3K | 0.00% | ↗ |
| 112 | 2012 | Mark R. Munch Ph.D. President, Bruker MAT Group and Bruker Nano Surfaces Division | 345.4K | — | — | — | 169.1K | 15.9K | 530.3K | 0.00% | ↗ |
| 113 | 2012 | William J. Knight Former Chief Financial Officer and Former Chief Operating Officer | 300.7K | — | — | — | 111.1K | 100.3K | 512.1K | 0.00% | ↗ |
| 114 | 2012 | Stephan Westermann | 223.6K | — | — | — | 129.5K | 13.4K | 366.5K | 0.00% | ↗ |
| 115 | 2011 | Frank H. Laukien Chairman, President and Chief Executive Officer | 433.3K | — | — | 113.0K | 338.5K | 7.4K | 892.1K | 12.66% | ↗ |
| 116 | 2011 | William J. Knight Chief Financial Officer and Former Chief Operating Officer | 362.0K | — | — | 104.4K | 92.3K | 8.3K | 566.9K | 18.42% | ↗ |
| 117 | 2011 | William J. Knight Former Chief Financial Officer and Former Chief Operating Officer | 362.0K | — | — | 104.4K | 92.3K | 8.3K | 566.9K | 18.42% | ↗ |
| 118 | 2011 | Brian P. Monahan Former Chief Financial Officer and Vice President of Strategic and Financial Planning | 280.4K | — | — | 62.6K | 89.8K | 7.4K | 440.1K | 14.23% | ↗ |
| 119 | 2010 | Frank H. Laukien Chairman, President and Chief Executive Officer | 423.4K | 50.0K | — | — | 702.7K | 7.4K | 1.18M | 0.00% | ↗ |
| 120 | 2010 | William J. Knight Former Chief Financial Officer and Former Chief Operating Officer | 355.0K | 20.0K | — | — | 195.4K | 8.3K | 578.7K | 0.00% | ↗ |
| 121 | 2010 | William J. Knight Chief Financial Officer and Former Chief Operating Officer | 355.0K | 20.0K | — | — | 195.4K | 8.3K | 578.7K | 0.00% | ↗ |
| 122 | 2010 | William J. Knight Chief Operating Officer | 355.0K | 20.0K | — | — | 195.4K | 8.3K | 578.7K | 0.00% | ↗ |
| 123 | 2010 | Brian P. Monahan Former Chief Financial Officer and Vice President of Strategic and Financial Planning | 275.0K | 20.0K | — | — | 162.8K | 7.4K | 465.2K | 0.00% | ↗ |
| 124 | 2010 | Brian P. Monahan Chief Financial Officer | 275.0K | 20.0K | — | — | 162.8K | 7.4K | 465.2K | 0.00% | ↗ |
| 125 | 2009 | Brian P. Monahan Chief Financial Officer | 193.2K | 168.8K | — | 688.0K | — | 6.8K | 1.06M | 65.11% | ↗ |
| 126 | 2009 | Brian P. Monahan Former Chief Financial Officer and Vice President of Strategic and Financial Planning | 193.2K | — | — | 688.0K | 168.8K | 6.8K | 1.06M | 65.11% | ↗ |
| 127 | 2009 | Brian P. Monahan Chief Financial Officer | 193.2K | — | — | — | 168.8K | 6.8K | 1.06M | 0.00% | ↗ |
| 128 | 2009 | Frank H. Laukien Chairman, President and Chief Executive Officer | 318.8K | — | — | 25.2K | 459.0K | 6.8K | 809.7K | 3.11% | ↗ |
| 129 | 2009 | Frank H. Laukien Chairman, President and Chief Executive Officer | 318.8K | 459.0K | — | 25.2K | — | 6.8K | 809.7K | 3.11% | ↗ |
| 130 | 2009 | William J. Knight Chief Financial Officer and Former Chief Operating Officer | 297.3K | — | — | 344.0K | 132.3K | 6.8K | 780.4K | 44.08% | ↗ |
| 131 | 2009 | William J. Knight Chief Operating Officer | 297.3K | — | — | — | 132.3K | 6.8K | 780.4K | 0.00% | ↗ |
| 132 | 2009 | William J. Knight Chief Operating Officer | 297.3K | 132.3K | — | 344.0K | — | 6.8K | 780.4K | 44.08% | ↗ |
| 133 | 2009 | Dirk D. Laukien Senior Vice President, President of Bruker Optics | 212.3K | — | — | — | — | 6.8K | 219.0K | 0.00% | ↗ |
| 134 | 2008 | Frank H. Laukien Chairman, President and Chief Executive Officer | 425.0K | — | — | — | 404.2K | 6.8K | 1.65M | 0.00% | ↗ |
| 135 | 2008 | Frank H. Laukien Chairman, President and Chief Executive Officer | 425.0K | 404.2K | 20.0K | 224.9K | — | 6.8K | 1.08M | 22.66% | ↗ |
| 136 | 2008 | William J. Knight Chief Operating Officer | 320.0K | 50.0K | — | — | 42.4K | 6.8K | 827.6K | 0.00% | ↗ |
| 137 | 2008 | Dirk D. Laukien Senior Vice President, President of Bruker Optics | 300.0K | 81.9K | 370.3K | — | — | 13.5K | 765.7K | 48.36% | ↗ |
| 138 | 2008 | William J. Knight Chief Operating Officer | 320.0K | 92.4K | 5.0K | 189.3K | — | 6.8K | 613.5K | 31.68% | ↗ |
| 139 | 2008 | Brian P. Monahan Chief Financial Officer | 200.0K | 20.0K | — | — | 24.1K | 6.8K | 373.4K | 0.00% | ↗ |
| 140 | 2008 | Brian P. Monahan Chief Financial Officer | 200.0K | 44.1K | 3.0K | 89.5K | — | 6.8K | 343.4K | 26.95% | ↗ |
| 141 | 2006 | Dirk D. Laukien Senior Vice President, President of Bruker Optics | 125.0K | — | 264.5K | — | — | 2.51M | 2.90M | 9.11% | ↗ |
| 142 | 2006 | Frank H. Laukien Chairman, President and Chief Executive Officer | 295.0K | 250.0K | 33.3K | 36.4K | — | 11.8K | 626.4K | 11.12% | ↗ |
| 143 | 2006 | William J. Knight Chief Financial Officer and Treasurer | 250.0K | 100.0K | 8.4K | 79.1K | — | — | 437.5K | 20.00% | ↗ |
| 144 | 2006 | Brian P. Monahan Corporate Controller, Executive Vice President of Bruker Daltonics | 165.0K | 41.5K | 5.0K | — | — | — | 211.5K | 2.36% | ↗ |
| 145 | 2004 | Brian P. Monahan Corporate Controller | 283.0K | — | — | 100.0K | — | 12.3K | 295.3K | 33.86% | ↗ |
| 146 | 2004 | Martin Haase Senior Vice President | 43.3K | — | — | 125.0K | — | — | 43.3K | 288.89% | ↗ |
| 147 | 2003 | William J. Knight Chief Financial Officer and Treasurer | 208.0K | 124.8K | — | 56.3K | — | 12.0K | 344.8K | 16.33% | ↗ |
| 148 | 2003 | Laura Francis Chief Financial Officer and Treasurer | — | — | — | — | — | — | — | — | ↗ |
| 149 | 2002 | Frank H. Laukien Chairman, President and Chief Executive Officer | 200.0K | 150.2K | — | 104.8K | — | 12.0K | 362.2K | 28.92% | ↗ |
| 150 | 2002 | John Hulburt Director of Audit and SEC Compliance | 200.0K | 150.2K | — | 104.8K | — | 12.0K | 362.2K | 28.92% | ↗ |
| 151 | 2002 | Martin Haase Senior Vice President | — | — | — | — | — | — | — | — | ↗ |
| 152 | 2002 | Brian P. Monahan Corporate Controller | — | — | — | — | — | — | — | — | ↗ |
| 153 | 2001 | Frank H. Laukien Chairman, President and Chief Executive Officer | 120.0K | 140.0K | — | 10.0K | — | 10.2K | 270.2K | 3.70% | ↗ |
| 154 | 2001 | John Wronka Vice President | 76.6K | 138.5K | — | 10.0K | — | 7.1K | 222.2K | 4.50% | ↗ |
| 155 | 2001 | Dieter Koch Director; Managing Director of both Bruker Daltonik GmbH and Bruker Saxonia Analytik GmbH | 116.7K | 75.5K | — | 10.0K | — | — | 192.2K | 5.20% | ↗ |
| 156 | 2001 | Laura Francis Chief Financial Officer and Treasurer | 128.5K | 40.3K | — | 15.0K | — | — | 168.8K | 8.89% | ↗ |
| 157 | 2001 | John Hulburt Chief Financial Officer and Treasurer | 128.5K | 40.3K | — | 15.0K | — | — | 168.8K | 8.89% | ↗ |
| 158 | 2001 | Ulrich Giessman Vice President | 114.9K | 30.6K | — | 11.0K | — | 3.9K | 149.4K | 7.36% | ↗ |
| 159 | 2000 | Frank H. Laukien Chairman, President and Chief Executive Officer | 114.7K | 124.0K | — | 25.0K | — | 9.9K | 248.5K | 10.06% | ↗ |
| 160 | 2000 | John Wronka Vice President | 72.7K | 157.0K | — | 12.5K | — | 10.2K | 239.9K | 5.21% | ↗ |
| 161 | 2000 | Dieter Koch Director; Managing Director of both Bruker Daltonik GmbH and Bruker Saxonia Analytik GmbH | 125.6K | 29.0K | — | 25.0K | — | — | 154.5K | 16.18% | ↗ |
| 162 | 2000 | Ulrich Giessman Vice President | 102.0K | 250.00 | — | 3.5K | — | — | 102.3K | 3.42% | ↗ |
| 163 | 2000 | John Hulburt Chief Financial Officer and Treasurer | 72.2K | 10.0K | — | 9.0K | — | — | 82.2K | 10.94% | ↗ |
| 164 | 1999 | Frank H. Laukien Chairman, President and Chief Executive Officer | 50.0K | 153.5K | — | — | — | — | 203.5K | 0.00% | ↗ |
| 165 | 1999 | John Wronka Vice President | 70.9K | 123.0K | — | — | — | 8.0K | 201.9K | 0.00% | ↗ |
| 166 | 1999 | Dieter Koch Director; Managing Director of both Bruker Daltonik GmbH and Bruker Saxonia Analytik GmbH | 117.1K | 36.5K | — | — | — | — | 153.6K | 0.00% | ↗ |
| 167 | 1999 | Ulrich Giessman Vice President | 75.0K | — | — | — | — | — | 75.0K | 0.00% | ↗ |
| 168 | 1999 | John Hulburt Chief Financial Officer and Treasurer | — | — | — | — | — | — | — | — | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Frank H. Laukien | Chairman, Chief Executive Officer & President | 2M | — |
| Mark R. Munch | Corporate Executive Vice President and President of Bruker Nano Group & Corporate | 1M | — |
| Gerald N. Herman | Executive Vice President & Chief Financial Officer | 879.3K | male |
| Falko Busse | President of Bruker BioSpin Group | 822.1K | — |
| Juergen Srega | President of Bruker CALID Group & Bruker Daltonics Division | 772.6K | male |
| Burkhard Prause | President and Chief Executive Officer of Bruker Energy & Supercon Technologies, Inc. | 596.0K | — |
| Thomas Bures | Chief Accounting Officer | — | male |
| J. Brent Alldredge | Senior Vice President, General Counsel, Secretary & Global Head of Compliance | — | male |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2023-05-23 | 2023-06-12 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2022-05-10 | 2022-06-10 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2020-11-27 | 2020-12-24 | Bob Gibbs | OH07 | — | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2019-11-14 | 2019-11-26 | Bob Gibbs | oH07 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2019-06-24 | 2020-04-27 | Donna Shalala | FL27 | -- | Sale (Full) | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BRKR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
